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ABSTRACT 
A plethora of literature examining the physiological consequences associated with 
deficits in energy availability (EA) for female athletes exists, however literature 
examining male athletes is sparse. Purpose: To determine the effects of high exercise 
energy expenditure (EEE) on Male Triad symptoms (EA with or without an eating 
disorder [ED], reproductive hormones Testosterone [T] and Luteinizing hormone [LH], 
and bone mineral density [BMD]) and other metabolic markers (Insulin, Leptin, Cortisol 
and Interleukin-6 [IL-6]) in endurance-trained male athletes.   Methods: We utilized a 
cross-sectional design on 14 endurance trained male athletes (age: 26.4 + 4.2 yrs.; weight: 
70.6 + 6.4 kg; and height: 179.5 + 4.3 cm) whom were recruited from the local 
community.  Two separate training weeks (low [LV] and high [HV] training volumes 
were collected including: dietary logs, exercise logs, BMD, and blood concentrations for 
6 hormones (T, LH, Insulin, Leptin, Cortisol, and IL-6).  Anthropometric measurements 
(height, weight, and body composition) were taken prior to data collection. Results: 
Overall, EA presented as 27.6 + 12.1 kcal/kg FFM·d  with 35% (n=5) of participants 
presenting with increased risk for ED. Examining Male Triad components: 1) 32.1% 
presented with LEA ( ≤ 20 kcal/kg FFM·d ) with or without ED, 2) Reproductive 
hormones T (1780.6 + 1672.6 ng/dL) and LH (813.7 + 314.2 pg/mL) were within normal 
limits compared to normative data, and 3) BMD was not compromised at 1.31 g/cm2.   Of 
those participants at risk for LEA (< 20 kcal/kg FFM·d ), 41.2% (n = 7) (HV: 50%, n = 4; 
LV: 33.3%, n = 3) demonstrated increased T levels (p = 0.20) while, 21.7% (n = 5) (HV: 
	  vi	  
18.2%, n = 2; LV: 25%, n = 3) presented with low Leptin levels (p = 0.01). Significant 
regressions revealed T levels from EA (F(1, 24) = 4.8, p = 0.04); RMR (F(1, 23) = 16.2, p 
< 0.001); EI (F(1, 24) = 6.7, p = 0.02), and DXA_BFP (F(1, 24) = 51.9, p < 0.001) and 
leptin levels from DXA_BFP (F(1, 24) = 27.2, p < 0.001). Conclusion:  This study is the 
first to examine all 3 components of the Male Triad.  We found 1 compromised 
component of the Triad (LEA with or without ED risk), however both reproductive 
hormones (T and LH) and BMD were not compromised.  Resultant LEA demonstrated a 
significant negative relationship with Leptin.  Relationships between body fat percent and 
the hormones T and Leptin demonstrated clinical uses for monitoring weight to assess 
hormonal profiles in males.  More research investigating negative physiological 
consequences associated with the Male Triad, decreased EI and increased EEE is needed 
in the male population.   
Key Words: Male Triad, Low Energy Availability, Bone Mineral Density, Testosterone, 
Luteinizing Hormone, Leptin.   
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CHAPTER 1 
INTRODUCTION 
 
Energy Deficiencies in Male Endurance Athletes  
Literature examining endurance athletes have demonstrated increased risks 
involving impaired physiological functions due to the high-energy expenditure demands 
of their sport participation.1-5 Examples of impaired physiological functions include: 
metabolic rate, protein synthesis, cardiovascular, and overall bone health.5-12 Low energy 
availability (LEA), also referred to as deficient energy availability, is defined as 
insufficient dietary energy intake to support the energy expenditure required for activities 
of daily life and the physical functioning of organs, muscles and other systems after the 
demands from the energy expenditure of exercise are met.5-13 Over 30 years of literature 
has examined female athletes in relation to LEA.  In 2014, the International Olympic 
Committee (IOC) issued a call for an encompassing model that addresses impaired 
physiological functions associated with deficient EA for all athletes; Relative Energy 
Deficiency in Sports (RED-S).11 In this issuance, the IOC describes RED-S as impaired 
physiological functions driven by relative energy deficiency leading to compromised 
functions of metabolic rate, menstrual function, bone health, immunity, protein synthesis 
and cardiovascular health in all athletes.11 While this appeal from the IOC demonstrates 
the need to examine populations other than women, including men and non-abled body 
athletes (e.g., Para-Olympic), RED-S does not have the empirical literature support for a  
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blanketed model encompassing females, males and non-abled body athletes at this point.  
Currently, literature examining deficient energy availability (EA) and its effect on 
physiological functions in male endurance athletes is limited.6 
 
Hormonal Responses    
Knowledge of the impact of deficient EA on male athletes and corresponding 
physiological systems is sparse. Established research on LEA in female athletes has 
shown negative health outcomes in various physiological systems including: 
cardiovascular, gastrointestinal, endocrine, reproductive, skeletal, renal and central 
nervous systems.5-13 Specifically for women, the high-energy demands of endurance 
exercise leads to concerns regarding (a) energy availability (EA), (b) menstrual cycle 
function, and (c) optimal bone health; also known as the female athlete triad (Triad).5-13 
The Triad has highlighted key factors of impaired physiological functions in women 
including; low energy availability, menstrual cycle dysfunction, and decreased bone 
health.5-13 Research has also highlighted LEA as a catalyst, which drives the Triad6,12 and 
spurns the acute and long-term reduction of hormonal and metabolic functions in the 
female athlete.6,11-13 Limited research has demonstrated deficient EA in males has 
negative effects and selected health risks associated with low gonadal and reproductive 
hormones.14-16  
 Upon examination of the research, a few trends have been established for male 
athletes.  Most recently, in 2016, Koehler et. al.,17 examined short-term EA reduction in 
exercising men. Energy availability for the males was reduced to 15 kcal/kg 
FFM·d resulting in the suppression of the hormones leptin and insulin. Additionally, 
	  3 
Friedl et. al.,16 examined chronic energy deficits on the thyroid, gonada-, and 
somatrotrophic –pituitary axes on US Army Rangers during training camp in an extreme 
semi-starvation, multi-stressor environment.  Gonadal and reproductive hormones (i.e. 
Testosterone (T), Thyroid, Sex Hormone Binding Globulin, and Insulin-like Growth 
Factor-I (IGF-I)) measured consistently low and were used as reliable and specific 
hormonal markers in assessing acute energy deficits in male U.S. Army Rangers while 
cholesterol and cortisol markers assessed a more chronic state of energy deficits in male 
U.S. Army Rangers.16  
 
Bone Mineral Density  
 Research has also revealed a trend in compromised bone mineral density (BMD) 
in male endurance athletes.18-20 Literature has shown 25%-63% of male cyclists 
(recreational and competitive road cyclists) were diagnosed with osteopenia within the 
spine and hip, while 9% of the competitive cyclists (~9 years of racing experience and 
training 7-22 hours/week) were diagnosed with osteoporosis at specific sites.16,18,20 While 
19% of runners demonstrated osteopenia within the spine and hip.18  Dolan et. al.,15 found 
similar hormonal outcomes in professional jockeys that Friedl et. al.,16 found in US Army 
Rangers.  More specifically, Dolan et. al.,15 found that with hormonal decrements, 
jockeys congruently had reduced bone mass and an elevated rate of bone loss due to this 
disruption in hormone activity in response to chronic weight cycling.  This congruent 
reduction of hormonal and BMD is akin with previous female literature suggesting a 
potential commonality to Triad-like symptoms in males.  There is inadequate research on 
the negative physiological effects and health outcomes associated with male athletes 
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participating in high-energy expenditure activities amid decreased energy needs with or 
without disordered eating/eating disorders (DE/ED).   
 
Disordered Eating/Eating Disorder Risk 
 Previous research has demonstrated women who train and compete in a LEA state 
have a 20%-48%1,21 higher prevalence of negative health outcomes, including nutrient 
deficiency, chronic fatigue, and increased infections and illness.6,7 While these outcomes 
are known in women, empirical deficient EA research is lacking in men relative to BMD, 
cardiovascular and reproductive systems.21 In females, LEA results from an inadequate 
dietary intake which may be present with or without an eating disorder (ED)/disordered 
eating (DE).5-13,21 Previous research has approximated only 8% of elite male athletes 
exhibit ED/DE.11 However, Martinsen and colleagues22 found the prevalence of DE in 
male athletes range from 10%-42%.   
 Mechanisms for LEA in women are reflective of either high exercise energy 
expenditure (EEE) or low energy intake (EI) with or without ED/DE’s.5-12 Mechanisms 
for deficient EA in male athletes have yet to be identified (ie. high EEE or EI with or 
without DE/ED’s). However, research demonstrates possible mechanisms including, long 
periods of restricted EI or rapid weight loss have demonstrated associations to other 
negative effects on cognitive function, growth, and sport performance.23 Hagmar and 
colleagues24  observed another psychological mechanism with male leanness in Olympic 
sport athletes and found these athletes had significantly lower body fat proportions, lower 
free T, lower leptin levels, and an increase in IGF-I levels.24 Some researchers believe 
due to the physiological characteristics specific to men, such as testosterone, males are 
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not as vulnerable to similar negative health outcomes associated with women and the 
Triad.11,15 However, research has demonstrated males in various sporting activities have 
similar physiological results to the Triad in relation to decreases in reproductive 
hormones, BMD, and compromised dietary intake.11,12   
 
Statement of Problem 
 Presently, limited research has identified males have similar mechanisms 
associated with reproductive health, bone health and EA; however it is unclear the extent 
of these outcomes.14  Koehler et. al.17 describes energy deficiency can lead to metabolic 
alterations, which are linked to long-term health outcomes and declares these outcomes 
need to be examined further to explore underlying mechanisms in relation to endocrine 
and metabolic responses in relation to energy deficits.  The IOC’s RED’s model confirms 
the need to examine the physiological effects of energy deficiency in male athletes.  De 
Souza et. al.,7 and Mountjoy et. al.,11 concur and have expressed that research examining 
energy deficiency in the male athlete is in its preliminary stages7,11 and continued 
research is necessary for male athletes specifically.11  De Souza et. al.,7 also stresses the 
importance of examining physiological differences amongst males and females 
independently and suggests the need to establish independent clinical guidelines specific 
to males and females.   
 
Manuscript 1: Specific Aims and Hypothesis 
Aim 1.1:  Examine the Male Triad symptoms (energy availability, reproductive function 
and bone mineral density) among endurance trained male athletes.      
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Hypothesis 1.1: Male endurance trained athletes will display at least one 
decreased component of either: EA, reproductive hormones (Testosterone [T] and 
Luteinizing Hormone [LH]) and/or bone mineral density.   
Hypothesis 1.2: Male endurance athletes who display deficient EA will have 
corresponding decreased symptoms of the other two components: decreased 
reproductive hormone (T and LH) and bone mineral density.    
 
Aim 2: Examine differences in EI, EA, EEE, and reproductive hormones (T and LH) 
between high-volume (HV) and low-volume training (LV) weeks.      
Hypothesis 2.1: Male endurance trained athletes will display differences in EI, 
EA, EEE, and reproductive hormones (T and LH) between the 2 training weeks. 
Hypothesis 2.2: Male endurance trained athletes will display a decrease in  
EI and EEE in the LV week  
Hypothesis 2.3: Male endurance trained athletes will display a decrease in EA 
and reproductive hormones (T and LH) in the in the HV week.   
Hypothesis 2.4: Male endurance trained athletes will display an increase in EEE 
in the HV week.  
 
Aim 3: Examine dietary behaviors regarding macronutrient profiles in male endurance 
trained athletes.   
Hypothesis 3.1: Male endurance trained athletes will display decreased 
carbohydrate (CHO) intake with increased protein (PRO) and fat intake in relation 
to the American College of Sports Medicine (ACSM) nutritional guidelines.   
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Aim 4: Examine pathogenic dietary behavior in endurance trained male athletes.     
Hypothesis 4.1: Male endurance trained athletes will display increased risks of 
ED/DE.    
Hypothesis 4.2:  Male endurance trained athletes who display increased risks of 
DE/ED will also demonstrate decreased energy availability.   
 
Manuscript 2: Specific Aims and Hypothesis 
Aim 1: Examine the effect of EA on reproductive (T and LH) and metabolic hormones 
(insulin, leptin, cortisol, and interleukin-6 [IL-6]) in male endurance trained athletes.     
Hypothesis 1.1: Endurance trained male athletes with deficient EA will present 
with increased metabolic hormone (cortisol and IL-6).   
Hypothesis 1.2: Endurance trained male athletes with deficient EA will present 
with and decreases in metabolic (insulin and leptin) and reproductive (T and LH) 
hormones.    
Hypothesis 1.3: Endurance trained male athletes without deficient EA will not 
demonstrate compromised metabolic markers.   
 
Aim 2: Examine differences in metabolic (insulin, leptin, cortisol and IL-6) and 
reproductive (T and LH) hormones between high-volume (HV) and low-volume training 
(LV) weeks.      
Hypothesis 2.1: Male endurance trained athletes will display differences in 
metabolic (insulin, leptin, cortisol and IL-6) and reproductive (T and LH) 
hormones between the 2 training weeks. 
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Hypothesis 2.2: Male endurance trained athletes will display a decrease in 
metabolic (insulin, leptin) and reproductive (T and LH) hormones in the HV 
training week.   
Hypothesis 2.3: Male endurance trained athletes will display an increase in 
metabolic (cortisol and IL-6) hormones in the HV training week.  
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CHAPTER 2 
MALE TRIAD SYMPTOMS AMONGST ENDURANCE-TRAINED MALE 
ATHLETES1 
  
1 Erin M. Moore, Toni M. Torres-McGehee, Clemens Drenowatz, Thaddus C. 
Brodrick, Brittany T. Williams, David F. Stodden, Justin M. Goins.  To be submitted 
to MedSci Sports Exerc. 
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ABSTRACT 
Literature examining the physiological consequences associated deficits in energy 
availability (EA) for male athletes is sparse. Purpose:  To examine Male Triad 
components (low energy availability [LEA] with or without an eating disorder [ED], 
reproductive hormones [testosterone (T), and Luteinizing hormone (LH)] and bone 
mineral density [BMD]) in endurance-trained male athletes. Methods: We utilized a 
cross-sectional design on 14 endurance trained male athletes (age: 26.4 + 4.2 yrs.; weight: 
70.6 + 6.4 kg; and height: 179.5 + 4.3 cm) whom were recruited from the local 
community.  Two separate training weeks (low [LV] and high [HV] training volumes 
were collected including: dietary logs, exercise logs, BMD, and blood concentrations for 
2 hormones (T and LH).  Anthropometric measurements (height, weight, and body 
composition) were taken prior to data collection. Results: Overall, EA presented as 27.6 
+ 12.1 kcal/kg FFM·d  with 35% (n=5) of participants presenting with increased risk for 
ED. Examining Male Triad components: 1) 32.1% presented with LEA (< 20 kcal/kg 
FFM·d ), 2) Reproductive hormones T (1780.6 + 1672.6ng/dL) and LH (813.7 + 314.2 
pg/mL) were within normal limits compared to normative data, and 3) BMD was not 
compromised at 1.31 g/cm2. Macronutrient profile demonstrated 92.9% were under-
consumed carbohydrates (CHO), 35.7% over-consume protein (PRO) and 42.9% over 
consumed fats compared to ACSM recommendations. Conclusion:  Within this study, 
endurance-trained male athletes presented with one compromised component of the Triad 
(LEA with or without ED risk).  Overall, both reproductive hormones (T and LH) and 
BMD were not compromised. Macronutrient profiles present similar to female literature, 
under-consuming CHO and over-consuming PRO and Fat.  These results suggest similar 
mechanistic behaviors to previous literature related to Triad symptoms in female athletes.  
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Further examination into physiological mechanisms of Triad symptoms is needed in the 
male athlete population.   
Key Words: Triad, Low energy availability, Bone mineral density, Testosterone, 
Luteinizing hormone.   
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Introduction 
The Female Athlete Triad (Triad) established 3 components (1) low energy 
availability (LEA) with or without eating disorder, (2) hypothalamic reproductive 
dysfunction, and (3) compromised bone mineral density (BMD).1,2 Energy availability 
markers for female athletes have been established at 45 kcal/kg FFM·d  for energy 
balance,2-10 and 30 kcal/kg FFM·d4-7,10,11 for LEA.  Previous literature found significant 
physiological changes, which occur at and below 30 kcal/kg FFM·d.4-7,10,11 These 
physiological changes include: metabolic rate declines, bone reabsorption increases, and 
protein synthesis breakdown occurs at this level, and changes in reproductive hormones 
(i.e., LH, FSH, and estrodral).2-7,10 These norms have not been established for the 
physically active male; therefore the Female Athlete Triad (Triad) Coalition and the 
International Olympic Committee (IOC) identified males as an under-researched 
population examining energy deficiency and its association to compromised 
physiological functions.3  
More specifically, examination of Triad symptoms has not been examined in male 
endurance runners. However, literature suggest sports emphasizing leanness (e.g., 
endurance sports, etc.) and sports requiring weight control may be at increased risk for 
nutritional deficits, and in turn be at risk for compromised physiology functions (e.g., 
decreased BMD, decreased hormonal response (leptin, insulin, and Testosterone [T]).12-19 
The American College of Sports Medicine (ACSM)20 has identified 3 categories 
describing the origins of energy deficiency in athletes; (1) lack of knowledge of energy 
needs based on demands of the energy expended, (2) clinical eating disorders and (3) 
intentional subclinical mismanagement of energy consumption to reduce body size and 
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fatness.20 This could include disordered eating behaviors similar to various eating 
disorders such as fasting and purging.20 Previously established research has examined and 
recognized the physiological differences in males and females, prompting De Souza et. 
al.,3 in response to the IOC’s REDs model, to stress the necessity to establish independent 
clinical guidelines in regards to energy deficiency and the physiological impacts 
specifically for males and females.   
To date, only one study has examined reduced energy availability (EA) set at 15 
kcal/kg FFM·d  in 6 exercising men and found decreases in leptin and insulin hormones, 
but not for Testosterone (T).17 However, Koehler et al. (2016)17 did not examine BMD.  
A second study examined 4 triathletes’ BMD and total T and revealed only 1 athlete’s Z-
score below -1.0 and 3 participants had low T levels (216 ng/dL to 242 ng/dL).21 
Previous literature examining male military populations assessed hormonal 
responses to extreme training environments and found negative physiological effects.14,18 
More specifically, examination of energy deficits in soldiers demonstrated with both high 
exercise energy expenditures (EEE) and decreased dietary energy intake (EI), 
reproductive hormone T decreased with energy deficits in males.17,18 Testosterone is 
considered a more robust hormone however, LH has proven critical during examination 
in female literature, due to its’ precursory control over estrogen (females) and T (males).  
Additionally, male cyclists and jockeys have demonstrated trends of decreased hormonal 
outcomes in relation to reduced bone mass22,23 and increased bone loss rates.12,13  
Due to high EEE demands of endurance sports, male endurance athletes may be at 
increased risk of Male Triad symptoms.  A review of literature found male athletes 
present similar symptoms to female athletes, with low caloric EI, lower reproductive 
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hormone levels (T), and decreased BMD.19 Tenforde et al. (2017)19 examined parallels 
between Triad symptoms in males and females and determined that for males, a better 
understanding of nutritional deficits including a definition of EA, confirmation whether 
disordered eating/eating disorder risk contributes to chronic energy deficits, and the 
relationship of EA to metabolic changes (specifically reproductive hormones and BMD) 
is needed. 
 Our study sought to examine Male Triad symptoms (energy availability [EA] 
with or without an eating disorder [ED], reproductive hormones [T an LH] and bone 
mineral density [BMD]) among endurance trained male athletes. We hypothesized 
endurance trained athletes would display at least one decreased component of the Male 
Triad.  A secondary purpose was to examine differences in energy needs (EI, EA, and 
EEE) and hormonal changes (T and LH) across 2 separate training volume weeks (high 
volume [HV] training week and low volume [LV] recovery week).  We hypothesized EI 
and EEE would be increased in the HV week and EA, T, and LH would be decreased in 
the HV week.  Third, we aimed to examine dietary behaviors regarding macronutrient 
profiles and eating disorder (ED) behaviors.  We hypothesized endurance trained athletes 
would display decreased carbohydrate (CHO) intake with increased protein (PRO) and 
fat intake in relation to the American College of Sports Medicine (ACSM) nutritional 
guidelines.24  
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Methods 
Participants 
Fourteen male participants (age: 26.4 + 4.2 yrs.; weight: 70.6 + 6.4 kg; and 
height: 179.5 + 4.3 cm) were recruited from the local community.  Specific inclusion 
criteria for participation included: participant is male, within a competitive season and 
actively training and racing >10 hours/week for at least 3 months,7,14,25 has a body fat 
percentage < 12%,7,13,14,25,26 has maintained weight stability (± 3 kg in past 6 months),17 
has a VO2max that is considered excellent to superior for age specific range (18-20 years: 
Excellent 51.0-55.9; Superior > 55.9 ml/kg/min, 20-29 years: Excellent 46.5-52.4; 
Superior > 52.4 ml/kg/min, 30-39 years: Excellent 45.0-49.4; Superior > 49.4 
ml/kg/min), 17,27 and was required to be independent of any injury that would prevent 
them from full participation in a high-endurance sport (running, triathlon, or obstacle 
racing).  
Specific exclusion criteria included any previous history of smoking, past or 
present diagnosis of clinical eating disorder, infectious disease within past 4 weeks, 
history of cardiovascular disease or orthopedic impairment that interferes with moderate 
to vigorous exercise, no history of thyroid or pituitary disease, use of medication, 
diabetes mellitus, known metabolic disease, and no long-term steroid use.  Institutional 
Review Board was obtained prior to the start of the study and all participants provided 
consent prior to participation.   
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Instruments and Protocols 
 Basic Demographic Survey.  Basic demographic information included: age; 
education level; ethnicity; exercise background; and pertinent medical history questions 
including known metabolic diseases, history of cardiovascular, thyroid, or pituitary 
diseases, and long-term steroid use were collected.  
Anthropometric Measurements.  Multiple anthropometric measurements were 
collected including height, weight, and body composition, which was measured 
according to ACSM standardized procedures.20 Height was measured with a 
Stadiomometer (Shorr Productions, Maryland) to the nearest 0.1 cm and weight was 
measured wearing minimal clothes to the nearest .01 kg with a scale (Tanita SC-331S 
Body Composition Scale, Tanita Co., Tokyo, Japan). Body fat was assessed using Tanita 
scale (Tanita SC-331S Body Composition Scale, Tanita Co., Tokyo, Japan) for inclusion 
criterion and Dual-Energy X-Ray Absorptiometry (DXA) (GE Lunar Prodigy 
densitometer) for data analysis.   
Dual-Energy X-Ray Absorptiometry (DXA). To measure bone mineral density 
(BMD) (g/cm2) of the total body, we used the DXA (GE Lunar Prodigy densitometer)2,20. 
It is the gold standard for bone mineral density assessment.20 Participants were instructed 
to: 1) not eat/overnight fast (12 hour fast), 2) refraining from vigorous exercise at least 15 
hours prior to scan, 3) no caffeine and alcohol consumption during the preceding 24 
hours, and 4) consume a normal evening meal the night before.20 Scoring of BMD was in 
either “normal” or “low” categories.  These categories were established from the T-scores 
and Z-scores.  The T-score is recognized the subject’s BMD score compared to the 
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average 30 year old adult.28  The Z-score is the subject’s BMD compared to the average 
score of subjects consisting of the same age, sex, weight, and ethnic or racial 
background.28 Scoring for the Z-score is considered “normal” when the scores fell 
between -1.0 and +1.0, and were considered “low” if scores fall below -1 and  -2.5.28 
Osteoporosis is a third category established with a Z-score below -2.5.28   
Resting Metabolic Rate (RMR). Used to identify how many calories are 
necessary at rest.  It was measured using indirect calorimetry (Microlife MedGem; 
HealtheTech, Golden, CO). The MedGem is a clinically-validated measurement device 
that assesses RMR.29 While the MedGem is not the gold standard for measuring RMR; it 
is, however, clinically a very relevant tool.29 Most accurate measurements are produced 
first thing in the morning, when the patient is rested and positioned in either a seated or 
semi-reclined position in a quiet room.29 Measurements should be implemented when the 
patient has not eaten, exercised or drank any caffeine within the last four hours.  
Total Daily Energy Expenditure (TDEE). Bodymedia SenseWear armbands 
continuously monitor TDEE and EEE. The armband is non-invasive, and participants 
wore it in all conditions (e.g., workouts, activities of daily life, sleeping) except to swim 
and shower.29-36 The armband has been validated compared to indirect caliometry, double 
labeled water, and VO2max metabolic cart. SenseWear© Software 8.0 was used to collect, 
save, and analyze data from the armband.29-37  
Exercise Energy Expenditure (EEE).  Two separate measurements were used to 
determine EEE; 1) Heart Rate Monitor (Garmin Forerunner 15) and 2) VO2max-HR 
Regression.  All results were reported as EEE in kcals.    
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1) Heart Rate Monitor. The participants wore a Garmin heart rate monitor 
(HRM) during exercise as a measure of EEE by calculating METs during 
exercise, derived from their HRM calculations. Various brands of HRM were 
found to accurately assess heart rates moderate activity (r > 0.90, SEE < 5 
beats/min).38  
2) VO2max-HR Regression. A VO2max treadmill test using the method from 
Beashel and Taylor (1996)39 targeted to endurance runners and the Parvo 
metabolic cart was administered as part of the inclusion criterion.  Calculated 
VO2max –HR regression slopes for each individual to match HR with EEE 
were used and reported in kcals.25 
Dietary Intake. Participants recorded 2 separate weeks, 7-consecutive days per week 
of dietary intake.  Portion sizes were explained, and take-home examples were given 
prior to food record distribution.  Dietary records were analyzed for total kilocalories and 
macronutrient (carbohydrates [CHO], proteins [PRO], and fat) consumption using a 
dietary analysis software program (ESHA food processor 8.0, Salem, OR).  Research has 
demonstrated that despite food intake restrictions, reported intake accuracy was superior 
using a 7-consecutive day weighted-diet record compared to a food-frequency 
questionnaire.  Food records were used to examine EI, macronutrient intake and EA.  
Macronutrients were analyzed using ACSM standards; CHO 6-10g/ kg for endurance 
runners, PRO 1.2-2.0g/kg, and Fats calculated as 20-35% of total kcals consumed.24           
Eating Disorder Inventory-3 (EDI-3) and Symptom Checklist (EDI-3 SC). The 
Eating Disorder Inventory-3 is a self-reported survey validated to identify subjects with 
disordered eating patterns.40 The inventory includes 91 items, organized into 12 primary 
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scales, consisting of three eating-disorder specific scales and nine general psychological 
scales that are relevant but not specific to eating disorders.40 The EDI-3 yields six 
composite scales, five general integrative psychological constructs (i.e. Ineffectiveness, 
Interpersonal Problems, Affective Problems, Over-control, and overall Psychological 
Maladjustment composite) and one eating disorder specific composite (Eating Disorders 
Risk Composite).40  The EDI-3 is validated for age ranges of adolescent (13 years of age) 
through elderly (53 years of age) subjects.40 Reliability for the EDI-3 composites are 
high.40 Coefficient and median values for specific composites include; Eating disorder 
risk (r=.98, median=.95) and General Psychological Maladjustment (r=.97, 
median=.93).40  
The EDI-3 SC is a screening tool designed specifically for Allied Health 
professionals to identify individuals at risk for eating disorders, providing information 
regarding the frequency of eating disorder risk behaviors or symptoms (i.e. binge eating, 
self-induced vomiting, exercise patterns, laxative use, diet pill use, and use of 
diuretics).40.40 EDI-3 Inventories (EDI-3 and EDI-3 SC) are copyright surveys from the 
Psychological Assessment Resources, Inc. and permission of use is granted with purchase 
of inventory.40 To be determined “at risk” for ED, participants must be identified as 
“Typical Clinical” or “Elevated Clinical” for at least 1 EDI Composite score, and/or meet 
the criteria for risk of pathogenic behavior (e.g., restricting, excessive exercise, binge 
eating, vomiting, laxatives, diet pills, etc.).  
Energy Availability (EA). Defined as the amount of dietary energy remaining after 
exercise, expressed as kcal/kg/free fat mass (EA = [EI – EEE] kcal/kg FFM·d).2 Energy 
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availability was examined using EI and EEE over 2 separate weeks of 7-consecutive 
days.  Low energy availability (LEA) was defined as < 20 kcal/kg FFM·d.         
Energy Balance (EB). Defined as the TDEE and dietary intake remaining at an 
equal level [dietary EI (kcals/day) = TDEE kcal/day)].  Energy balance was examined 
using dietary EI and TDEE over two 7-consecutive day weeks and will be defined as, 1) 
negative EB [EI < TDEE], 2) positive EB [EI > TDEE], or 3) balanced EB [EI = 
TDEE].2-8,10,41 
Hormone Measures. All fasting blood samples were acquired with 24 hours of 
non-physical activity at the completion of each 7-consecutive day week.  Blood samples 
were centrifuged, and plasma drawn out to assess T and LH using enzyme-linked 
immunosorbent assay (ELISA) Kits specific for each hormone.  This study used enzyme-
linked immunosorbent assay (ELISA) kits specific for T and LH.  Research has shown 
ELISAs to report specific and highly sensitive procedures for identify various substances.  
Sensitivities of ELISAs are high, 1-10 ug/liter range with the correlation coefficient were 
reported between 0.95-0.99.42  Establishment of cutoffs were identified as 1) low, 2) 
within normal limits, or 3) high based on previously established normative data specific 
for males (adult and age range specific) associated for T, while LH used the standard 
curve for the ELISA kit.  The ranges include the following for reproductive hormones: T 
= 270-1070 ng/dL (average 679 ng/dL)43  and LH = 140 pg/mL–10,000 pg/mL.       
 Training Conditions. Two separate training weeks were used to assess 
differences between energy needs and hormones.   
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1) High Volume Training Week (HV).  A high-volume training week consists 
of at least 5 days of training and includes at least 10 hours of training with in a 
7-consecutive day week.   
2) Low Volume Training Week (LV).  Low-volume training week, or a 
recovery week, was described as an unloading week for the participant.  No 
specific requirements were established except participants were asked to work 
out a minimum of 2-3 days for the 7-consecutive day week.   
Detailed Procedures 
 The data collection spanned across 2 separate weeks consisting of 1 day for an 
information and initial measurement session, and two 7-consecutive day weeks where 1 
week was during the low volume/recovery week (LV), and 1 week was during the high 
volume-training week (HV).   
Part I Recruitment:  
Participants were recruited from local area running clubs and races.  An 
information letter via email was used to give a brief overview of the study.  All 
participants interested were individually corresponded with to set-up assigned dates and 
times for informational sessions and anthropometric measurements.  
Part II Data Collection: 
  Informational Session: Participants attended an orientation session prior to the 
data collection sessions.  This session consisted of a written and verbal overview of the 
study, participant expectations, instructions from the researchers describing various tools 
	  24 
used during data collection including: ESHA FoodProdigy, BodyMeida SenseWear 
Armband, and Heart Rate Monitor  
Prior to Data Collection:  Participants first completed a series of surveys, a brief 
interview, used to follow up on medical history, physical measurements (height, weight, 
and percent body fat), V02max test, and resting metabolic rate (RMR).  Blood Draws and 
DXA scans were scheduled for the 2 separate weeks of data collection.  Blood draws 
consisted of 2 tubes (2.4 tsp) during each data collection.  A total of 2 data collection 
sessions occurred, accumulating in 4 tubes (4.8 tsp) for the entire study.        
 Data Collection: Participants completed 2 separate 7-consecutive day weeks at 2 
different levels of training volume (High/training and Low/recovery).  All equipment 
(e.g., BodyMedia SenseWear Armband, HRM, and food log entry information) was 
provided on Day 1 and instructions were given both oral and written via email.  Data 
collection HV week was a “normal” week with a minimum of 5 training days/week and 
participants were engaged in a competitive season.  The procedures for each of the 2 
weeks were identical; the only change was their volume load (HV and LV).     
 Training Weeks: Participants were instructed to not change their daily/weekly 
activities and physical activity/exercise, while recording their food and daily training for 
7-consecutive days.  They were instructed to wear the armband for 23 hours/day and 
wear a HR monitor only during exercise during training for the 7-consecutive days. At 
the end of the 7-consectuve day training week, participants came in for a fasting blood 
draw and DXA scan.  All equipment was returned and the next week was scheduled.    
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Statistical Analysis  
 IBM SPSS statistical Software (version 24; SPSS Inc., Chicago, IL) and an alpha 
< 0.05 was used for all analyses.  Based upon power analysis a priori and based upon 
means of previous literature from Koehler et. al.,17 and Loucks et. al.,11 an effect size 
between 1.0 and 3.0 yielded a sample size of 6-10 subjects.  Using the Wilcoxon signed 
rank test, 14 subjects allowed for full saturation.  Descriptive statistics for all dependent 
variables were calculated.  Frequencies and proportions with 95% confidence intervals 
were calculated for all categorical variables (Male Triad symptoms: at risk for LEA [with 
or without and ED], at risk for reproductive dysfunction, and at risk for Low BMD, 
pathogenic behaviors [e.g., restricting, excessive exercise, vomiting, etc.], and 
macronutrient assessment. Chi-square analysis were used to examine “at risk” for LEA, 
“at risk” for ED, and macronutrient profile compared to ACSM recommendations.     
A 2 (week) X 7 (days) ANOVA and paired T-tests assessed differences between 
the two training weeks for EEE, EA, TDEE, EB, EI, and macronutrients.  Paired T-tests 
were used to determine differences between the 2 training weeks and variables (e.g., 
Testosterone, LH, EEE, and EA).  Pearson’s correlation and regressions were used to 
examine relationships between EA and reproductive hormones.   
 
Results 
 Eighteen participants began the study, 1 dropped out due to fear of needles and 3 
were eliminated for lack of compliance with the required procedures of the study, 
yielding a total of 14 participants.  Participants criterion demonstrated a VO2max 62.3 + 
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6.9 ml/kg/min, FFM 65.7 + 5.4 kg, and a DXA BFP 13.6 + 3.5%.  Ethnicity of 
participants demonstrated 78.6% Caucasian (n = 11), 14.3% African American (n = 2) 
and 7.1% Middle Eastern (n = 1).  Education levels revealed 92.9% (n = 13) had some 
level of college and higher.  Specifically, 28.6% (n = 4) attained some level of college, 
21.4% (n = 3) attained a bachelor’s degree, 35.7% (n = 5) attained a master’s degree, and 
7.1% (n = 1) attained a clinical doctorate, and 1 participant (7.1%) attained a GED.  
Overall distance was 49.2 ± 78 miles (HV: 63.4 ± 100.6 miles and LV: 34.9 ± 45.4 miles) 
with no significant difference between the 2 training weeks (F (1,26) = 0.93, p = 0.34).  
Overall training time was 5.6 ± 4.3 hours per week (HV: 7.1 ± 5.3 hours and LV: 4.1 ± 
2.5 hours) with no significant difference between the 2 training weeks (F (1,26) = 3.74, p = 
0.06).     
Triad- Symptoms: Overall, zero participants met the criteria for all 3 Male Triad 
components (LEA, reproductive dysfunction, and low BMD), and no participates were at 
risk solely for reproductive dysfunction and low BMD. When examining LEA with or 
without ED risk using EEE from Garmin HRM, 32.1% (n = 9) of participants presented 
with LEA over the 2 training weeks (HV: 35.7%, n = 5; LV: 28.6%, n = 4).  Twenty 
percent (n = 2) of participants presented having LEA with the risk of ED (HV: 20%, n = 
1; LV: 20%, n = 1), while 38.9% (n = 7) of participants presented having LEA without 
the risk of ED (HV: 44.4%, n = 4; LV: 33.3%, n = 3).  When examining LEA with or 
without ED risk using EEE from V02max-HR regression, 32.1% (n = 9) of participants 
presented with LEA over the 2 training weeks (HV: 35.7%, n=5; 28.6%, n = 4).  Thirty 
percent (n = 3) of participants presented having LEA with the risk of ED (HV: 40%, n = 
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2; LV: 20%, n = 1), while 33.3% (n = 6) of participants presented having LEA without 
the risk of ED (HV: 33.3% n = 3; LV: 33.3% n = 3).   
Energy Assessment: All means and standard deviations for energy needs 
assessment data (e.g., RMR, EI, EA etc.) can be found on Table 2.1. A 2 (training 
conditions: HV, LV) x 7 (days) ANOVA and paired T-tests were used for EA, EI, EEE, 
TDEE and EB.  Overall EA_HRM was 29.7 ± 10.5 kcal/kg FFM·d (95% CI: 24.9, 34.5 
kcal/kg FFM·d) and overall EA_VO2max Regression was 30.2 kcal/kg FFM·d (95% CI: 25.6, 
34.7 kcal/kg FFM·d).  Paired t-tests demonstrated an average EA for both measurements: 
1) EA_HRM: HV week: 26.9 + 9.6 kcal/kg FFM·d and LV week: 29.5 + 11.2 kcal/kg 
FFM·d  (t(13) = -1.37, p = 0.15); and 2) EA_VO2max Regression: HV week: 25.2 + 12.9 
kcal/kg FFM·d  and LV week: 29.9 + 11.1 kcal/kg FFM·d  (t(13) = -1.61, p = 0.13).  No 
significant differences were elicited between training weeks and EA.  Regarding both 
training weeks, examination in the specific daily LEA account can be found in Table 2.1.     
With or without an Eating Disorder. Overall, 35.7% (n = 5) of participants 
presented with at risk for composite scales EDI-3 (all data found in Table 2.2 and Table 
2.3).  Most participants did not demonstrate a specific risk for ED risk subscales and/or 
composite scale.  Within the interpersonal problem composite (IPC), 21.3% (n = 3) 
scored as typical clinical, with the two subscales of 20% (n = 3) scoring typical clinical 
on the interpersonal insecurity (II) scale, and within the interpersonal alienation (IA) 
scale 21.4% (n = 3) scored typical clinical.  The over control composite (OC) presented 
with 28.6% (n = 4) scoring typical clinical with the two subscales presenting 50.0% (n = 
7) with typical clinical scores of and 7.1% (n = 1) elevated clinical scores for 
perfectionism scale and 21.4% (n = 3) typical clinical scores of Asceticism scale.  
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Maturity fears presented with the highest scores between all the sub-scales with 35.7% (n 
= 5) demonstrating typical clinical scores and 21.4% (n = 3) with elevated clinical scores.  
Two participants (14.3%) were identified as using restrictive behaviors while 42.9% (n = 
6) of the participants used exercise to lose weight.  Four participants (28.6%) used 
exercise to lose weight < 25% of the time while 14.3% (n = 2) used exercise for weight 
loss between 25%-50% of the time.   
 Energy Intake and Macronutrient Profile. One-way repeated-measures ANOVA 
(assumptions of sphericity were met due to only 2 weeks assessed) were calculated to 
compare difference across the 2 training weeks for EI and macronutrients (CHO, PRO, 
and Fats).  Overall EI was 2658.9 ± 887.1 kcals (95% CI: 2314.9, 3002.9) and overall 
macronutrient intake demonstrated CHO: 4.9 ± 1.7g (95% CI: 4.2, 5.8), PRO: 1.7 ± 0.6 g 
(95% CI: 1.5, 1.9), and Fat: 32.3 ± 5% of total kcals (95% CI: 30, 34.6).  No significant 
effect was found between the HV and LV training weeks for the following variables: EI: 
F(1,13) = 2.04; (p = 0.18), CHO: F(1,13) = 0.15; (p = 0.70), PRO: F(1, 13) = 1.26; (p = 
0.28), and fat: F(1,13) = 0.004; (p = 0.95).  Consumption of macronutrients demonstrated 
decreased CHO intake during both weeks, specifically 92.9% (n = 13) were below the 
recommendations in the HV week and 78.6% (n = 11) were below during the LV week.  
During the HV week, 35.7% (n = 5) were above the recommendations for protein, 21.4% 
(n = 3) were below recommendations for protein.  Whereas, during the LV week, 28.6% 
(n = 4) over consumed protein and only 14.3% (n = 2) under consumed compared to the 
ACSM recommendations for protein.  Participants (42.9%, n = 6) over-consumed fats 
during the HV week, while 35.7% (n = 5) over-consumed fat during the LV week.  Chi-
squares demonstrated that those presenting with LEA through Garmin HRM 
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demonstrated 36% (n = 9) under-consumed CHO, 33.3% (n = 2) under-consumed 
protein, and 20% (n = 2) over-consumed fats, while V02max-HR regression demonstrated, 
36% (n = 9) under-consumed CHO, 66.7% (n = 4) under-consumed protein, and 30% (n 
= 3) over-consumed fats.  Pearson’s chi-square tests demonstrated no statistically 
significant association between overall EA_VO2max Regression and CHO χ (2) = 1.6, p = 
0.21, and overall EA_HRM and Fats χ (2) = 0.03, p = 0.87.  However, overall PRO did 
demonstrate a significant association to EA_HRM χ (2) = 7.8, p = 0.02 (HV: χ (2) = 5.5, p = 
0.06; LV: χ (2) = 2.4, p = 0.31) as well as the training weeks of Fat (HV: χ (2) = 4.3, p = 0.04; 
LV: χ (2) = 3.8, p = 0.05).  When examining associations of EA_HRM to micronutrition’s, 
only overall PRO (χ (2) = 7.1, p = 0.03) and Fat HV week (χ (2) = 4.3, p = 0.04) demonstrated 
statistically significant results. 
      Exercise Energy Expenditure: Two measurements were used to assess EEE.  Due 
to missing data cells (determined by when participants exercised) an ANOVA was not 
used for EEE.  A paired samples t-test was calculated to compare the mean of the 2 
training weeks (HV and LV).  The mean of HV week using Garmin HRM was 919.3 + 
538.2 kcals and the mean for the LV week using Garmin HRM was 696.5 + 472.7 kcals.  
A significant difference between the 2 training weeks (HV vs. LV) was elicited (t (13) = 
3.5; p = 0.004). The mean of HV week using VO2max-HR regression was 1048.5 + 805.6 
kcals and the mean for the LV week was 682.3 + 326.5 kcals.  No significant difference 
between the 2 training weeks (HV vs. LV) was elicited (t (13) =1.7; p = 0.10).   
Total Daily Energy Expenditure and Energy Balance: Participants TDEE for both 
weeks was 2993.0 + 160.8 kcal, (HV: 3073.1 + 180.5 kcals, LV: 2912.9 + 149.4 kcals) 
which resulted in an overall negative EB of -139.3 + 201.0 kcal, (HV: -289.4 + 220.9 
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kcals and LV: 10.7 + 205.6 kcals).  There was no significant main effect found between 
the training weeks and TDEE: F (1,11) = 4.02, (p = 0.07) or EB: no main effect F (1, 11) = 
4.40, (p = 0.06).   
Hormones: A paired samples t-test was calculated to compare the means between 
the 2 training weeks (HV and LV) for T and LH.  The mean for T was 1764.5 + 1598.2 
ng/dL (95% CI: 959.3, 1398.4) (T_HV: 1640.5 + 1385.3 ng/dL and T_LV: 1888.3 + 
1831.1 ng/dL.  The mean for LH was 795.6 + 313.9 pg/mL (95% CI: 612.7, 794.9) 
(LH_HV: 385.7 + 191.0 pg/mL and LH_LV: was 409.9 + 119.9 pg/mL.  No significant 
differences were found between the 2 training weeks and T (t (12) = -1.47 p = 0.17) or LH 
(t (12) = -0.79, p = 0.44).  Neither T nor LH presented low compared to normative male 
value.  A Pearson correlation coefficient was calculated for the relationship between T, 
LH and other variables. A strong positive correlation was found for both weeks; HV: (r 
(13) = 0.77, p = 0.002) and LV: (r (13) = 0.84, p < 0.001), indicating a significant linear 
relationship between the LH and BFP.  A strong negative correlation was found for 
overall T to EI: (r (26) = -0.47, p = 0.02), RMR: (r (26) = -0.64, p < 0.001), and a strong 
positive correlation for overall T to DXA_BFP (r (26) = 0.83, p < 0.001).   
Testosterone (T): Two outliers were removed prior to regression analysis was ran.  
A simple linear regression was calculated to predict participant’s T levels based on their 
EA.  The regression equation was not significant (F (1,23) = 3.2, p = 0.89) with an R2 of 
0.12.  Energy availability is not a significant predictor of T levels. A simple linear 
regression was calculated to predict participants’ T levels based on their RMR.  A 
significant regression equation was found (F (1,23) = 16.23, p < 0.001), with an R2 of 0.4.  
Participants’ predicted T level is equal to 3123.5 + -0.97(RMR) ng/dL when RMR is 
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measured in kcals.  Participants’ average T levels decreased -0.97 ng/dL for each kcal of 
RMR.  A simple linear regression was calculated to predict participants’ T levels based 
on their EI.  A significant regression equation was found (F (1, 24) = 6.7, p = 0.02), with an 
R2 of 0.22.  Participants’ predicted T level is equal to 2591.9 + -0.44(EI) ng/dL when EI 
is measured in kcals.  Participants’ average T levels decreased -0.44 ng/dL for each kcal 
of EI.  A simple linear regression was calculated to predict participants’ T levels based on 
their DXA_BFP.  A significant regression equation was found (F (1, 24) = 51.9, p < 0.001), 
with an R2 of 0.83.  Participants’ predicted T level is equal to -1273.5 + 197.2 
(DXA_BFP) ng/dL when DXA_BF is measured in kg.  Participants’ average T levels 
increased by 197.2 ng/dL for each kg of DXA_BFP.  A significant association was 
demonstrated between EA_VO2max Regression and overall T (χ (2) = 4.4, p = 0.04) and T 
from the HV week (χ (2) = 5.8, p = 0.02).  No other significant relationships were found.         
Luteinizing Hormone (LH): Four outliers were removed prior to regression 
analysis.  A simple linear regression was calculated to predict participant’s LH levels 
based on their EA.  The regression equation was not significant (F (1,22) = 1.6, p = 0.22) 
with an R2 of 0.07.  EA is not a significant predictor of LH levels.  A simple linear 
regression was calculated to predict participant’s LH levels based on their DXA_BFP.  
The regression equation was not significant (F (1,22) = 2.08, p = 0.16) with an R2 of 0.09.  
The DXA_BFP is not a significant predictor of LH levels.  No other significant 
relationships were found.         
Bone Mineral Density: Total bone density was 1.3 + 0.1 g/mc2 with a Z-score of 
1.3 + 0.9 g/mc2 suggesting overall, participants did not present with compromised bone 
health.  Overall measurements from the DXA scan included a T-score of 1.1 + 1.1 g/mc2 
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and specific areas of the body including Legs 1.4 + 0.1 g/mc2, Pelvis 1.2 + 0.2 g/mc2, and 
Spine 1.2 + 0.1 g/mc2 indicating a healthy level of BMD.  
 
Discussion:  
 In this study, we sought to identify and measure all 3 components of the Male 
Triad, LEA with or without an ED (set at 20 kcal/kg FFM·d), hypogonadotropic 
hypogonadism19 (T and LH), and BMD across 2 separate training volume weeks (HV and 
LV).  Our overall results supported our hypothesis that endurance trained male athletes 
would exhibit at least one component of the Male Triad.  We found that 32.1% exhibited 
LEA (with or without an ED); however, our participants did not demonstrate decreased 
reproductive hormones (T and LH) or decreased BMD either with or without LEA. 
Energy Availability 
Within this study, 2 separate training weeks (HV and LV) were used to examine 
energy needs and demands specific to EA, EI including macronutrients (carbohydrates, 
proteins, and fats), and pathogenic eating behaviors, EEE, TDEE, and EB.  To assess EA, 
we created a cutoff point for LEA at < 20 kcal/kg FFM·d.  Our results yielded an average 
EA of 25.2 kcal/kg FFM·d (HV week) and 29.9 kcal/kg FFM·d (LV week).  These results 
demonstrated considerably lower overall EA compared to Reed et al. (2013)44 study of 
free-living NCAA Division I female soccer players presenting with EA (LEA set at < 30 
kcal/kg FFM·d ) at ~42 kcal/kg FFM·d  in pre-season, ~32 kcal/kg FFM·d  in mid-
season, and ~43 kcal/kg FFM·d  in post-season.  While overall neither week 
demonstrated LEA using VO2max-HR Regression EA, 71.4% (n = 10) of the participants 
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demonstrated LEA between 1 and 4 days during both HV and LV weeks. There currently 
is no research examining free-living EA in males to compare our results with.   
The EEE seen in this study was congruent with previous studies in females. Melin 
et al.19 reported an average of 879 kcal EEE, with participants who presented with LEA 
reported EEE of 1222 kcal in female elite endurance athletes. Reed et al.18 reported an 
average of approximately 800 kcal during preseason and 600 kcal midseason in free 
living female collegiate soccer athletes. Conversely, the female recreational athletes 
represented in this study reported an average of 531 kcal EEE. Therefore, the participants 
in this study did not have to exercise at the same level as seen in those collegiate and elite 
athletes to demonstrate LEA. This may be due to the great decrease in EI mentioned 
before. As the participants in this study did not eat as much as seen in the previous 
studies, the participants did not require as high of a level of EEE to put them at risk for 
LEA. 
However, EEE seen in this study was far lower compared to male participants in 
other studies. In Friedl et al.10 study on army rangers, the estimated EEE was 
approximately 4000 kcal/day, whereas Dolan et al.16 estimated EEE on race days for 
professional jockeys was 3952 kcal. The male participants in this study’s EEE were only 
a fraction of that amount at an average of 687.8 kcal. This may be due to a few reasons, 
1) the military operation studies required significant EEE demands, while our study 
examined free- living runners and 2) the other studies may be defining and calculating 
EEE in a different way than we did in our study.   
Dietary EI did not reveal a statistical difference between the 2 training weeks, 
suggesting male endurance-trained athletes are not changing their EI in relation the 
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demands of the training volumes.  This may be due to a lack of nutrition knowledge or 
may be related to pathogenic behaviors.  Caloric EI (2658.9 + 230.4 kcals/day) was lower 
compared to male and female mountain runners (3199 + 701 kcal/day) pre-race day diet45 
and higher compared to female endurance runners during regular training (Low: 2140 + 
130 kcals) and intensified training (INT: 2318 + 343 kcals).46 Another study examining 
EI specifically in males was Malinauskas et al.47 study, which examined game (home and 
away) days and a non-game day during a summer league college baseball season.  The 
baseball players caloric intake for 3161 + 709 kcals/day on non-game days, 2968 + 26 
calories/day for home game days, and 2679 + 701 kcals/day for away game days 
compared to our EI of 2658.9 + 230.4 kcals during active competitive racing season.   
The macronutrient profile of our participants was similar to previous research 
within female athletes, specifically, the under consumption of CHO and over 
consumption of PRO and fats.2,8,44 This is concerning as because within the female 
literature, LEA is the catalyst for negative physiological functions associated with the 
Triad.1 Koehler et al.17 (in males) and Loucks et al.7 (in females) have both demonstrated 
LEA is elicited with or without exercise, which emphasizes the importance of proper 
nutritional practices throughout training.  Within our participants, we did not notice a 
significant difference between the EA and the training weeks, but the HV training week 
did demonstrate a lower EA.  This decrease in EA, was not due to a change in EI, but 
rather to a significant difference noted in EEE with the LV training week eliciting lower 
EEE kcals. 
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Low Energy Availability: With or Without an Eating Disorder   
 Overall, 35.7% presented with an increase eating disorder (ED) risk.  This is 
elevated compared to the limited research on male athletes.  Research has estimated 5% 
of elite male athletes present with anorexia nervosa or bulimia nervosa specifically48 and 
another 1% of males represent “other specified feeding or eating disorders”.49 Norwegian 
researchers found 13.5% of both male and female athletes were diagnosed with a clinical 
and/or subclinical ED.50 When compared to non-athletes (4.6%), this was twice as high 
for the athletes.50 Sundgot-Borgen et. al.50 also demonstrated endurance athletes 
presented with 9% diagnosed ED, which was higher than ball-game athletes with 5% 
diagnosed ED.  There is limited research examining specific eating disorders prevalence 
in male athletes.  Rates in males are currently unknown for anorexia nervosa, however an 
estimated 10:1 ratio has been demonstrated for females to males.51 
 The EDI-3 has specific composite and sub-scale scores which examine specific 
behavioral traits similar to those diagnosed with EDs, with “typical clinical” and 
“elevated clinical” scores indicating increased risk factors for EDs.  Two specific 
psychological risks identified in the over-control composite, demonstrated 57.1% were 
classified as typical and elevated clinical for perfectionism and maturity fears. The over-
control composite reflects the significant need to avoid disappointing others as well as be 
the best and contains sub-scales perfection (P) and asceticism (A).  The sub-scale 
perfectionism is important to note, as this sub-scale is a distinguishing feature of EDs as 
well as for athletes in general, which is demonstrated in this study, with over 50% of our 
participant had typical or elevated scores.  
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 Males also presented with pathogenic eating behaviors, similar to females. One 
pathogenic behavior, like female athletes, includes using exercise for weight control.  
With 28.6% using exercise to lose weight < 25% and another 14.3% using exercise to 
lose weight between 25%-50%.  Research suggests 37% of male athletes (age 18-22) 
exercise 2 or more hours per day for the purposeful intention to burn calories.52 Similar to 
the female literature, elite male athletes participating in sports that require leanness 
(endurance running) shows increases in ED risk.49 However, to date the literature focused 
on ED is limited and there is not the ability to compare male athletes to other male 
control groups.49    
Energy Balance 
Endurance-trained male athletes demonstrated negative EB (-289.4 kcals) in the 
HV training week, which eliciting concern as this is indicative of poor fueling to meet the 
demands of EEE and TDEE.  Previous research has demonstrated prolonged negative EB 
can lead to decreases in EA and decreased physiological processes.6 The disparity 
amongst EB and EA is that an athlete can have LEA but maintain their EB.  This is due to 
the suppression of various physiological processes due to the lack of EA.6 Strubbs et. 
al.,53 provided an example of the contrast between EB and EA.  Eight lean men had a 
suppressed caloric energy intake and an increased exercise energy expenditure resulting 
in a constant energy availability of 30 kcal/kg FFM·d.53 Strubbs et. al.,53 found the 
negative energy balance decreased towards zero at a rate of 90kcal/day due to the 
decreased physiological processes, and estimated 3 weeks for participants to elicit an EB 
of zero while stilling remaining in a severely LEA state.53   
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Reproductive Hormones 
 We did not see a decrease in Testosterone (T) in either training week.  This may 
be due in part to the large “normative” range of T. Both weeks demonstrated larger 
values than the “normal” range of 270-1070 ng/dL. With the average for both weeks high 
(HV: 1640.6 + 1385.3 ng/dL and LV: 1888.3 + 1831.1 ng/dL), this was not congruent 
with most of the literature examining endurance runners. Testosterone is considered a 
more robust hormone, with delays in response to external stimuli (i.e., decreased body 
fat54, increased mileage).55-57  One thought is the “volume threshold” proposed by De 
Souza and Miller,58 that found decreases in T when participants trained at  >100km/week, 
which our participants met in the HV week for distance but did not demonstrate decreases 
in T.  As this study was observational in nature, EA (~25-29 kcal/kg FFM·d) and body fat 
percentages (~13.5%) may not have been low enough, or EEE (~670 kcals) or mileage 
(~49 miles; HV ~63 miles; LV: ~34) may not have been high enough, to elicit adverse 
reactions and decreases in T levels.  Our results are congruent with Koehler et al.,17 
whom examined 6 cyclists and did not show a decrease in T when EA was acutely 
reduced to 15 kcal/kg FFM·d  for 4 days.  We were not able to calculate a prediction 
equation for T or LH using EA, however using RMR, EI and DXA_BFP demonstrated 
significant regressions equations to predict T levels in male endurance-trained athletes.  
This could be impactful for clinicians whom do not have access to specific blood testing.      
 Luteinizing hormone did not demonstrate a significant difference between the 2 
weeks.  Freidl et al.,14  2001 examined LH in US Army Rangers during Ranger school (8 
weeks) and found soldiers presented with low LH levels during high training volume.  
This may have been due to the sudden and dramatic decrease in EI with simultaneous 
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dramatic increase in EEE resulting in an average body fat percentage under 5% during 
the 8 weeks.  Our results found a positive correlation between LH and BFP, and previous 
literature may suggest a link with BFP and hormonal deficits14-16,54 
Bone Mineral Density 
No participants in this study demonstrated low BMD, however 29% (n=4) 
participants ranged from -0.4 to 0.9 including an African American participant with a 
BMD at -0.4, which was interesting due to African American BMD typically is more 
dense in comparison to Caucasians.59 Also, 2 participants were well over a Z-score of 2; 
these were Obstacle course runners and therefore did large amounts of weight lifting 
along with endurance running.  Limited research examining male endurance runners have 
demonstrated similar risks to female endurance runners.60 However, it has been 
demonstrated that endurance runners have equal or higher BMD compared to inactive 
controls, but lower BMD compared to higher-impact sports.  Many participants were 
active in a weight lifting regimen, which may be related to the adequate BMD levels and 
increased T levels.          
 
Limitations and Future Research:  
There were limitations identified in this study examining energy needs, hormones 
and BMD.  First, EI collection was a self-reported measurement, however 7-day recall 
has been found to be more reliable and valid compared to food frequency questionnaires 
and 3-day recalls.61   The use of mechanical equipment including the armband, HR 
monitor, as well as participant operator error may have had an influence during data 
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collection.  Examination of EEE was calculated using HRM and Vo2max-HR regression.  
Double-labeled water would be a more accurate method to estimate EEE.  The DXA 
scans were of total body and not segmental.  Segmental scans should be used in the future 
to examine specific sites including spine and femur.  Luteinizing Hormone is pulsatile in 
nature, and while we only measured it once as a fasting draw to give a gross overview of 
LH, a more accurate multi-draw technique to assess the pulsatile nature of LH is 
preferred.  Future research should examine reproductive hormones more specifically in 
relation to LH to examine the pulsatile nature of the hormones response, and possibly 
examining sperm count to assess the output measures of LH and T in males.      
 
Conclusion  
 This is the first study to examine all 3 components of the Male Triad (EA with or 
without an ED, hypogonadotropic hypogonadism [T and LH], and BMD) of endurance-
trained male athletes in a free-living setting.  Our study demonstrated the endurance-
trained males presented with 1 compromised component of the Triad, LEA with or 
without ED was demonstrated.  While reproductive hormones and BMD were not 
negatively affected, this study provides results that demonstrate the need for further 
examination of the Male Athlete Triad.  Also, with the compromised macronutrient 
profile and our participants demonstrating pathogenic dietary behaviors, further research 
is needed to examine specific nutritional behaviors, EA with or without ED and the 
corresponding physiological health markers of male athletes.  The mechanistic nature 
seen in the female population with EA set at 30 kcal/kg FFM·d needs to be assessed and 
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identified in the male population. Currently, there is no set cut-off point for LEA in the 
male population or a clear understanding of physiological consequences for males 
regarding Triad symptoms. More research examining male athletes and the Male Triad 
needs to be conducted.     
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TABLES 
Table 2.1:  Energy need assessments and macronutrient intake for Endurance Trained Male 
Athletes (n=14). Values are presented in Mean ± Standard Deviation. 
  ALL 
  M SD 
Energy Needs Assessment    
 Resting Metabolic Rate (kcals)  1799.3 549.0 
 Energy Intake (kcals)  2658.9 230.4 
 Exercise Energy Expenditure (kcals)-
GHR 
 636.7 127.1 
 Exercise Energy Expenditure (kcals)-VO2  865.4 566.1 
 Energy Availability (kcal/kg FFM·d)-
GHR* 
 28.2 10.4 
 Energy Availability (kcal/kg FFM·d)-
VO2* 
 27.6 12.0 
      
Low Energy Availability Risk  HV% N LV%  N 
 LEA < 2 days per week-GHR  42.8 6 35.7 5 
 LEA 3-4 days per week-GHR  21.4 3 21.4 3 
       
 LEA< 2 days per week-VO2  35.7 5 50.0 7 
 LEA 3-4 days per week-VO2  35.7 5 21.4 3 
       
 LEA < 2 days per week-Arm  35.7 5 21.4 3 
 LEA 3-4 days per week-Arm  21.4 3 28.6 4 
 LEA 5-6 days per week-Arm  21.4 3 21.4 3 
 LEA 7 days per week-Arm  7.7 1 7.7 1 
       
Macronutrients  HV Mean HV SD LV Mean LV SD 
 CHO g  327.9 35.1 329.0 35.8 
 CHO g/kg  4.6 0.5 4.7 0.5 
 PRO g  122.9 12.0 119.8 11.5 
 PRO g/kg  1.7 0.2 1.7 0.1 
 Fat kcal  96.8 11.4 93.7 10.6 
 Fat (%)  31.6 1.7 31.5 1.4 
       
*Note: LEA for the week was calculated by taking the average of the 7 days of EA. LEA = low 
energy availability; GHR = Garmin Heart Rate Monitor; VO2=VO2max-HR Regression; 
Arm=Armband.  EEE- calculated by the average number of days of exercise /week across 
individuals 
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Table 2.2: Eating disorder characteristics among Endurance Trained Male Athletes (n=14).  Data 
is presented in frequency (n) and percent (%).  
  EDI Classification 
 Raw Score Low 
Clinical 
Typical 
Clinical 
Elevated 
Clinical 
 Mean SD n % n % n % 
Eating Disorders Risk Scale         
 Drive for Thinness (DT) 1.6 2.4 14 100 - - - - 
 Bulimia (B) 0.9 1.9 13 92.9 1 7.1 - - 
 Body Dissatisfaction (BD) 1.6 2.4 14 100 - - - - 
 Eating Disorder Risk Composite 
(EDRC) 
82.3 5.8 14 100 - - - - 
          
Psychological Scale         
 Low Self-Esteem (LSE) 2.2 3.8 13 92.9 1 7.1 - - 
 Personal Alienation (PA) 1.9 2.3 14 100 - - - - 
 Interpersonal Insecurity (II) 4.9 4.4 11 78.6 3 21.4 - - 
 Interpersonal Alienation (IA) 3.4 3.2 10 71.4 4 28.6 - - 
 Interceptive Deficits (ID)  0.8 1.1 14 100 - - - - 
 Emotional Dysregulation (ED) 0.6 0.8 14 100 - - - - 
 Perfectionism (P) 10.1 4.3 6 42.9 7 50 1 7.1 
 Asceticism (A) 5.4 3.8 11 78.6 3 21.4 - - 
 Maturity Fears (MF) 7.1 5.8 6 42.9 5 35.7 3 21.4 
          
Composite         
 Ineffectiveness Composite (IC) 63.1 9.6 13 92.9 1 7.1 - - 
 Interpersonal Problems Composite 
(IPC) 
76.3 11.5 11 78.6 3 21.4 - - 
 Affective Problems Composite 
(APC) 
66.6 2.1 14 100 - - - - 
 Over control Composite (OC) 80.6 12.4 10 71.4 4 28.6 - - 
 General Psychological 
Maladjustment (GPMC) 
331.1 30.5 14 100 - - - - 
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Table 2.3. Eating disorder pathogenic behaviors among 
endurance trained male athletes (n=14). Data is presented in 
frequency (n) and percent (%) 
  All Data 
Exercise to Control Weight N % 
  0% of time 8 57.1 
  <25% of time 4 28.6 
  25%-50% of time 2 14.3 
  More than 75% of time 0 0 
  100% of time 0 0 
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Table 2.4: Hormone and bone mineral density values for Endurance Trained 
Male Athletes (n=14). Values are presented in Mean ± Standard Deviation. 
Hormones  M SD 
 Testosterone ng/dL  1780.6 1672.6 
 Luteinizing Hormone pg/mL  813.7 314.2 
     
Bone Mineral Density  M SD 
 Total Z-score  1.30 0.96 
 Total Score (g/cm2)  1.31 0.01 
 Legs (g/cm2)  1.40 0.12 
 Spine(g/cm2)  1.17 0.13 
 Pelvis (g/cm2)  1.22 0.16 
*Hormones and BMD were measured after 24 hours of rest and as AM fasting 
 
 
 
 
  
	  49 
FIGURES 
 
 
Figure 2.1: Testosterone levels as a function of V02max-HR Regression Energy 
Availability in endurance-trained male runners.  Testosterone measured ng/dL and 
Regression EA measured in kcal/kg FFM·d , n= 26; p = 0.89.    
 
	  50 
 
 
Figure 2.2: Luteinizing Hormone levels as a function of V02max-HR Regression Energy 
Availability in endurance-trained male runners.  LH measured pg/mL and Regression EA 
measured in kcal/kg FFM·d , n= 24; p = 0.22.   	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Figure 2.3: Testosterone levels as a function of Body Fat Percentage in endurance-
trained male runners.  Testosterone measured ng/dL and DXABFP measured in 
percentage (%); (r (24) = 0.83, p < 0.001). 	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Figure 2.4: Luteinizing Hormone levels as a function of Body Fat Percentage in 
endurance-trained male runners.  LH measured pg/mL and DXABFP measured in 
percentage (%), p < 0.001. 	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Figure 2.5: Testosterone levels as a function of Energy Intake in endurance-trained male 
runners.  Testosterone measured ng/dL and EI measured in kcals, n = 26; (r (24) = -0.47, p 
= 0.02).  A significant regression equation was found (F (1, 24) = 6.7, p = 0.02), with an R2 
of 0.22. 
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Figure 2.6: Testosterone levels as a function of Resting Metabolic Rate in endurance-
trained male runners.  Testosterone measured ng/dL and RMR measured in kcals; (r (26) = 
-0.64, p < 0.001). A significant regression equation was found (F (1,23) = 16.23, p < 0.001), 
with an R2 of 0.4. 
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CHAPTER 3 
EXAMINATION OF ENERY AVAILABILITY ON HORMONAL PROFILE OF 
ENDURANCE TRAINED MALE ATHLETES2 
 
 
 
 
 
 
 
 
 
2Erin M. Moore, Toni M. Torres-McGehee, Clemens Drenowatz, Brittany T. 
Willaims, Thaddus C. Brodrick, David F. Stodden, Justin M. Goins.  To be submitted 
to Journal of Sports Sciences. 	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ABSTRACT 
Examination of the negative physiological effects due to decreased energy availability 
(EA) in male athletes is not understood. Purpose: Examine the effect of EA on 
reproductive (Testosterone [T] and Luteinizing Hormone [LH]) and metabolic hormones 
(Insulin, Leptin, Cortisol, and Interleukin-6 [IL-6]) in male endurance-trained athletes. 
Methods: We utilized a cross-sectional design on 14 endurance trained male athletes 
(age: 26.4 + 4.2 yrs.; weight: 70.6 + 6.4 kg; and height: 179.5 + 4.3 cm) who were 
recruited from the local community.  Participants completed 2 separate training weeks 
(low [LV] and high [HV] training volumes) and each week included: 7-day dietary logs, 
7 day-exercise logs, and one blood draw each week to determine concentrations for 6 
hormones (T, LH, Insulin, Leptin, Cortisol, and IL-6).  Anthropometric measurements 
(height, weight, and body composition) were taken prior to data collection.  Results: 
Participants at risk for LEA (≤ 20 kcal/kg FFM·d), demonstrated 41.2% (n = 7), HV: 
50%, n = 4; LV: 33.3%, n = 3) had increased T levels (p = 0.20).  Of those participants 
with LEA, 21.7% (n = 5) (HV: 18.2%, n = 2; LV: 25%, n = 3) presented with low Leptin 
levels (p = 0.01). Significant regressions revealed T levels from RMR (F(1, 23) = 16.23, 
p < 0.001); EI (F(1,24) = 6.7, p = 0.02), and DXA_BFP (F(1, 24) = 51.9, p < 0.001) and 
leptin levels from DXA_BFP (F(1, 24) = 27.18, p < 0.001).  Conclusion:  Overall, 
participants demonstrated LEA, which highlighted a significant negative relationship 
between LEA and Leptin. Relationships between BFP and T, BFP and Leptin both 
demonstrate more clinical uses for clinicians in monitoring males’ weight and hormonal 
profiles for those without access to blood testing.  These results suggest that BFP impacts 
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endurance-trained male athletes’ hormonal profiles.  Ultimately, insights on the near and 
long-term health outcomes for male athletes are needed. 
Key Words:  Energy Availability, Testosterone, Luteinizing Hormone, Insulin, Leptin, 
Interleukin-6.   
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As high-energy exercise in the elite sport realm has been popular (e.g., soccer, 
cycling, running, etc.); a new fad of sports such as ultramarathons, extreme challenge 
races and triathlons have developed to promote physical activity, increase community 
involvement in exercise, and used as a counter-measures to obesity.  This increase 
participation in high-energy exercise has changed from purely elite sport participation to 
the recreational athletes.  Endurance runners are unique athletes due to the high-energy 
expenditure physical demands within their sport. These increased demands escalate 
endurance athletes’ (e.g. distance runners) risk of impaired physiological functions (e.g., 
decreased hormonal profile [Testosterone (T), leptin, insulin, increased cortisol, 
decreased BMD, and compromised macronutrient profile)1-9 however it is unclear how 
male endurance athletes’ impairments are compared to the well-established research of 
female endurance athletes.1-9  
Energy Availability  
Research examining energy availability (EA) and the resultant physiological 
effects of low EA (LEA) in male athletes is currently unknown. The only study to 
examine short-term EA reduction in exercising men demonstrated significant suppression 
of leptin and insulin hormones due to the reduction of EA to 15 kcal/kg FFM·d in 6 
exercising men, which are similar results to Loucks et. al.,10,11 research in exercising 
female athletes.  Other male research has examined chronic energy deficits and its effect 
on various hormones;12-19 however, EA was not calculated or examined specifically.  
Within the Female Triad, LEA has been established at ≤ 30 kcal/kg FFM·d 3-6,9,11 due to 
significant physiological changes, including metabolic rate declines, bone reabsorption 
increases, protein synthesis breakdown occurs, and reproductive hormones decrease (i.e., 
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Luteinizing hormone [LH], Follicular stimulating hormone [FSH], and estrodral).1-6,9 To 
date, there are no established LEA markers for the male athlete.  Mechanisms responsible 
for energy deficiency in athletes include; 1) lack of knowledge of energy needs based on 
demands of the energy expended, (2) clinical eating disorders and (3) intentional 
subclinical mismanagement of energy consumption to reduce body size and fatness.13 
Due to physiological differences between males and females, De Souza et. al.,2 stresses 
the necessity to establish independent clinical guidelines regarding LEA and the 
physiological impacts specifically for males.   
Hormones 
Military research has shown male soldiers during occupational missions are 
exposed to dietary restrictions and increases in EEE causing compromised EA.14,18  Fridel 
et. al.,14 examined 2 separate groups of US Army Rangers during their 8-week Ranger 
course.  During these 8 weeks; 4 cycles of restricted energy intakes (EI) and re-feeding, 
incorporating specific EI deficits of 1,000-1,200 kcal/day occurred.14 Due to deficits in EI 
and high EEE in the male US Army Rangers, gonadal and reproductive hormones 
(testosterone (T), thyroid, sex hormone-binding globulin, and insulin-like growth factor I 
(IGF-I)) were consistent markers to use when assessing acute energy deficits.14 Cortisol 
and cholesterol were specific hormonal markers, which assessed the chronic state of 
energy deficits in the male US Army Rangers.14 Congruently, Kryolainen et. al.18 
examined hormonal alterations during prolonged military field exercises in Finnish 
soldiers and the effect of various energy deficits prompted through different exercise 
intensity and consistent EI.  Results revealed an average energy deficit (difference 
between EEE and EI) of 4,000 kcal/day in phase I of training (one week long) 
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demonstrated significant increases in cortisol (+32%) and growth hormone (+616%) 
where exhibited while insulin (-70%), total T (-27%) and free T (-26%) decreased.18  
Once energy deficits were reduced (<1,000 kcal/day in Phases II and III), all hormonal 
markers stabilized.18 Understanding the mechanistic nature of hormonal alterations in 
relation to decreased EI, increased EEE, and compromised EA is needed.  The roles of 
hormones (T, LH, Insulin, Leptin, Cortisol, IL-6) have demonstrated associations to 
various physiological functions including the hypothalamic-pituitary axes, which in part 
controls reproductive and metabolic processes.  These physiological functions can be 
suppressed by 1) decreased EI, 2) increased EEE, or 3) a combination of both.  Specific 
roles for each hormone are listed below.    
 Reproductive Hormones.  Testosterone is a steroid hormone produced in the testes 
(specific for males) and adrenal cortex.20 Testosterone stimulates development of male 
secondary sexual characteristics.20 The mechanistic nature of decreased T is currently 
unknown, however research directs to one impression that involves dysfunctions in the 
hypothalamic-pituitary-testicular regulatory axis.21 Another reproductive hormone 
includes LH.  Luteinizing hormone in males stimulates the production of testosterone and 
in part, aids in the role of sperm production.22 Previous literature suggests exercise 
intensity plays an important role in relation to LH outcomes (positive and negative).23 
Other results suggest a hypothalamic gonadotropin-releasing hormone deficiency may 
occur due to suppression from other hormones (e.g., cortisol) related to training.24 
Establishing mechanistic behaviors (decreased EA and EI and/or increased EEE) for 
decreases in reproductive hormones (T and LH) need to be determined.     
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 Metabolic Hormones.   Insulin is a peptide hormone and produced from Beta cells 
within the islets of Langerhans in the pancreas and contributes an important role in 
metabolism.25 Insulin aids in the absorption of glucose into muscle, fat, and liver cells for 
energy.25 Insulin also stimulates muscle and liver tissue to store excess glucose in the 
form of glycogen, in turn suppressing gluconeogenesis by the liver.25 Two mechanisms 
have been suggested for decreased insulin including 1) adaptations of glucose uptake in 
runners and 2) a global effect on the hypothalamic-pituitary axes.3,25   
Leptin, a metabolic hormone, is an adipoocytokine hormone that affects neurons 
in the hypothalamus responsible for the regulation of body mass loss and satiety 
regulating dietary energy intake and energy expenditure.26 Circulating leptin levels are 
influenced by exercise and glucose uptake and through sympathetic and direct 
mechanism which induces increase of fatty acid disposal in metabolism.26 Leptin 
stimulates appetite suppression and reduces the level of brain chemicals that stimulate 
appetite.26 Leptin receptors have various actions due in large part to the numerous types 
of tissues that contain leptin receptors.26 Most prominent tissues include the skeletal 
muscle and the liver.26 Previous literature has demonstrated a parallel relationship of 
leptin and body weight suggesting an acute reduction of leptin is linked to an acute 
metabolic signal for energy conservation. 26,27 Research has also demonstrated key 
endocrine axes (reproductive, growth hormone, IGF-I, and thyroid axes) are associated to 
reduced leptin levels.27 The synergistic effect of body weight and leptin and leptin’s 
associations with other hormones establishes an endocrine effect that needs to be 
understood in relation to Male Triad symptoms.   
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A third hormone with associations and effect on other hormones include cortisol.  
Cortisol is the primary hormone related to stress (physical, psychological and 
physiological) and is a glucocorticoid hormone from the adrenal cortex.28 Cortisol has 
various roles in the body including increasing glucose up-regulation into the bloodstream 
and brain, inhibits nonessential functions that would be detrimental in a “flight-or fight” 
state, and alters the immune system response.28 Cortisol has demonstrated the ability to 
decrease functions of other systems (reproductive, digestive, and growth processes) and 
high cortisol levels over time have adverse effects on health. 28 With specific effects on 
the reproductive and metabolic processes through hypothalamic-pituitary axes due to 
changes in EI, EEE, and body composition, examination of compromised EA and its 
effect on the male endurance-trained athletes’ hormonal profile needs to be assessed.   
A pro-inflammatory hormone that has local and global effects is Interleukin-6.  
Interleukin-6 is a cytokine produced in the skeletal muscle and released systemically.  It 
has many functions including induction of lipolysis, stimulation of cortisol production, 
and suppression of tumor necrosis factor alpha (TNF) production, another cytokine 
involved in systemic inflammation.29,30 During exercise and low muscle glycogen levels, 
IL-6 is activated,29 and Pedersen et al.,29 demonstrated CHO supplementation during 
exercise blunted IL-6 release in muscles.  These reproductive and metabolic hormones 
are all associated with physiological effects related to exercise intensity, high EEE, low 
EI, as well as actions on other hormones.  With this involvement, understanding the 
endurance-trained male athletes’ hormonal profiles during decreased EI and/or 
compromised EA needs to be examined further.   
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Currently, there is inadequate literature existing for male athletes who participate 
in high-energy expenditure activities with decreased energy needs.  Understanding the 
physiological demands and consequences of energy needs in male athletes is critical for 
acute and long-term health and prevention of injuries and illness.  Existing literature has 
established long periods of restricted energy intake or rapid weight loss in male athletes 
have an affiliation to negative hormonal effects.12,14-19,31 Our study sought to examine the 
effect of EA on reproductive (T and LH) and metabolic hormones (insulin, leptin, 
cortisol, and interleukin-6 [IL-6]) in male endurance-trained athletes.  We hypothesized 
endurance-trained athletes who displayed LEA would present with decreased 
reproductive (T and LH) and metabolic (Insulin and Leptin) hormones as well as 
increased metabolic hormones (cortisol and IL-6).  A secondary purpose was to examine 
differences in reproductive (T and LH) and metabolic (Insulin, Leptin, Cortisol and IL-6) 
hormones between the 2 training (HV and LV) weeks.  We hypothesized male 
endurance-trained athletes would display a difference between the 2 training weeks.  
Third, we aimed to examine secondary measures (EI, EEE, DXA_BFP, RMR, and 
mileage) and their relationships to the reproductive (T and LH) and metabolic hormones 
(Insulin, Leptin, Cortisol, IL-6).  We hypothesized some of the secondary measures 
would demonstrate a relationship with the hormones (i.e., increased mileage would have 
a negative effect on the hormonal profile).    
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Methods 
Participants 
Fourteen male participants (age: 26.4 + 4.2 yrs.; weight: 70.6 + 6.4 kg; and 
height: 179.5 + 4.3 cm) were recruited from the local community.  This study was part of 
a larger study conducted and therefore shares similar methodology.  Specific inclusion 
criteria for participation included: participant is male, within a competitive season who is 
actively training and racing >10 hours/week for at least 3 months,6,14,32 has a body fat 
percentage ≤ 12%,6,12,14,32,33 has maintained weight stability ( ± 3 kg in past 6 months),17 
has a VO2max that is considered excellent for age specific range (18 - 20 years: Excellent 
51.0 - 55.9 ml/kg/min; 20 - 29 years: Excellent 46.5 - 52.4 ml/kg/min; 30 - 39 years: 
Excellent 45.0 - 49.4 ml/kg/min),17,34 and was required to be independent of any injury 
that would prevent them from full participation in a high-endurance sport (running, 
triathlon, or obstacle racing).  
Specific exclusion criteria included no previous history of smoking, past or 
present diagnosis of clinical eating disorder, infectious disease within past 4 weeks, 
history of cardiovascular disease or orthopedic impairment that interferes with moderate 
to vigorous exercise, no history of thyroid or pituitary disease, use of medication, 
diabetes mellitus, known metabolic disease, and no long-term steroid use.  Institutional 
Review Board was obtained prior to the start of the study and all participants provided 
consent prior to participation.   
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Instruments and Protocols 
 Basic Demographic Survey.  Basic demographic information including: age, 
education level, ethnicity, exercise background, and pertinent medical history questions 
including known metabolic diseases, history of cardiovascular, thyroid, or pituitary 
diseases, and long-term steroid use were collected.  
Anthropometric Measurements.  Multiple anthropometric measurements were 
collected including height, weight, and body composition, which were measured 
according to ACSM standardized procedures.13 Height was measured with a 
Stadiomometer (Shorr Productions, Maryland) to the nearest 0.1 cm and weight was 
measured wearing minimal clothes to the nearest .01 kg with a scale (Tanita SC-331S 
Body Composition Scale, Tanita Co., Tokyo, Japan). Body fat was assessed using a 
Tanita scale (Tanita SC-331S Body Composition Scale, Tanita Co., Tokyo, Japan) for 
inclusion criterion and Dual-Energy X-Ray Absorptiometry (DXA) (GE Lunar Prodigy 
densitometer) for data analysis.   
Dual-Energy X-Ray Absorptiometry (DXA). The gold standard for body fat 
percentage (BFP) measurement and bone mineral density assessment.13 Participants were 
instructed to: 1) not eat/overnight fast (12 hour fast), 2) refraining from vigorous exercise 
at least 15 hours prior to scan, 3) no caffeine or alcohol consumption during the 
preceding 24 hours, and 4) consume a normal evening meal the night before.13 Scoring of 
BFP was reported in percentage.    
Resting Metabolic Rate (RMR). Used to identify how many calories are 
necessary at rest.  It was measured using indirect calorimetry (Microlife MedGem; 
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HealtheTech, Golden, CO). The MedGem is a clinically-validated measurement device 
that assesses RMR.35 While the MedGem is not the gold standard for measuring RMR; it is, 
however, a clinically a very relevant tool.35 Most accurate measurements are produced 
first thing in the morning, when the patient is rested and positioned in either a seated or 
semi-reclined position in a quiet room.35 Measurements should be implemented when the 
patient has not eaten, exercised or drank any caffeine within the last four hours.  
Exercise Energy Expenditure (EEE).  Two separate measurements were used to 
determine EEE; 1) VO2max-HR Regression and 2) Heart Rate Monitor (Garmin 
Forerunner 15).  All results were reported as EEE in kcals.    
1) VO2max-HR Regression. A VO2max treadmill test using the method from 
Beashel and Taylor (1996)36 targeted to endurance runners and the Parvo 
metabolic cart was administered as part of the inclusion criterion.  Calculated 
VO2max –HR regression slopes for each individual to match HR with EEE 
were used and reported in kcals.32 
2) Heart Rate Monitor. The participants wore a Garmin heart rate monitor 
(HRM) during exercise as a measure of EEE by calculating METs during 
exercise, derived from their HRM calculations. Various brands of HRM were 
found to accurately assess heart rates moderate activity (r ≥ 0.90, SEE < 5 
beats/min).37  
Dietary Intake. Participants recorded 2 separate weeks, 7-consecutive days per 
week of dietary intake.  Portion sizes were explained, and take-home examples were 
given prior to food record distribution.  Dietary records were analyzed for total 
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kilocalories consumption using a dietary analysis software program (ESHA food 
processor 8.0, Salem, OR).  Research has demonstrated that despite food intake 
restrictions, reported intake accuracy was superior using a 7-consecutive day weighted-
diet record compared to a food-frequency questionnaire.  Food records were used to 
examine EI and EA.   
Energy Availability (EA). Defined as the amount of dietary energy remaining 
after exercise, expressed as kcal/kg/free fat mass (EA = [energy intake–EEE] kcal/kg 
FFM·d).1 Energy availability was examined using EI and EEE over 2 separate weeks of 
7-consecutive days.  Low energy availability (LEA) was defined as < 20 kcal/kg FFM·d.         
Hormone Measures. All fasting blood samples were acquired with 24 hours of 
non-physical activity at the completion of each 7-consecutive day week.  Blood samples 
were centrifuged, and plasma drawn out to assess 6 different hormones (Testosterone [T], 
Luteinizing Hormone [LH], Insulin, Leptin, Cortisol, and Interluekin-6 [IL-6]) using 
enzyme-linked immunosorbent assay (ELISA) Kits specific for each hormone. This study 
used ELISA kits specific for T, LH, Insulin, Leptin, Cortisol, and IL-6.  Research has 
shown ELISAs to report specific and highly sensitive procedures for identify various 
substances.  Sensitivities of EISAs are high, 1-10ug/liter range with the correlation 
coefficient were reported between 0.95-0.99.38   
Establishment of cutoffs were identified as 1) low, 2) within normal limits, or 3) 
high based on previously established normative data specific for males (adult and age 
range specific) associated for T, Insulin, Leptin, Cortisol, and IL-6 while LH used the 
standard curve from the ELISA kit. Normative ranges for each hormone includes: T = 
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270 - 1070 ng/dL (average 679 ng/dL)39, LH = 1.8-12.0 mlU/L,39,40 fasting insulin = < 5 
ulU/mL (8 - 10 ulU/mL is also an accepted range),41 leptin = 1.2 -9.5 ng/ml,42 cortisol 
specific to the morning includes: 7 - 28 ug/dL, and IL-6 = < 1.8 pg/mL.43     
 Training Conditions. Two separate training weeks were used to assess 
differences between energy needs and hormones.   
1) High Volume Training Week (HV).  A high-volume training week consists 
of at least 5 days of training and includes at least 10 hours of training with in a 
7-consecutive day week.   
2) Low Volume Training Week (LV).  Low-volume training week, or a 
recovery week, was described as an unloading week for the participant.  No 
specific requirements were established except participants were asked to work 
out a minimum of 2-3 days for the 7-consecutive day week.   
 
Detailed Procedures 
The data collection spanned across 2 separate weeks consisting of 1 day for an 
information and initial measurement session, and two 7-consecutive day weeks where 1 
week was during the high volume-training week (HV) and 1 week was during the low 
volume/recovery week (LV).     
Part I Recruitment:  
Participants were recruited from local area running clubs and races.  An 
information letter via email was used to give a brief overview of the study.  All 
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participants interested were individually corresponded with to schedule assigned dates 
and times for informational sessions and anthropometric measurements.  
Part II Data Collection: 
  Informational Session: Participants attended an orientation session prior to the 
data collection sessions.  This session consisted of written and verbal overview of the 
study, participant expectations, instructions from the researchers describing various tools 
used during data collection including: ESHA FoodProdigy, BodyMeida SenseWear 
Armband, and Heart Rate Monitor  
Prior to Data Collection:  Participants first completed a series of surveys, a brief 
interview, used to follow up on medical history, physical measurements (height, weight, 
and percent body fat), V02max test, and resting metabolic rate (RMR).  Blood Draws and 
DXA scans were scheduled for the 2 separate weeks of data collection.  Blood draws 
consisted of 2 tubes (2.4 tsp) during each data collection.  A total of 2 data collection 
sessions occurred, accumulating in 4 tubes (4.8 tsp) for the entire study.        
 Data Collection: Participants completed 2 separate 7-consecutive day weeks at 2 
different levels of training volume (HV and LV).  All equipment (e.g., BodyMedia 
SenseWear Armband, HRM, and food log entry information) was passed out and 
instructions were emailed.  Data collection HV week was a “normal” week with a 
minimum of 5 training days/week and participants were engaged in a competitive season.  
The procedures for each of the 2 weeks were identical; the only change was their volume 
load (HV and LV).     
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 Training Weeks: Participants were instructed to not change their daily/weekly 
activities and physical activity/exercise, while recording their food and daily training for 
7-consecutive days.  They were instructed to wear the armband for 23 hours/day and 
wear a HR monitor only during exercise during training for the 7-consecutive days. At 
the end of the 7-consectuve day training week, participants came in for a fasting blood 
draw and DXA scan.  All equipment was returned and the next week was scheduled.    
 
Statistical Analysis  
 IBM SPSS statistical Software (version 24; SPSS Inc., Chicago, IL) and an alpha 
≤ 0.05 was used for all analyses.  Based upon power analysis a priori and based upon 
means of previous literature from Loucks et. al.,11 and Koehler et. al.,17 an effect size 
between 1.0 and 3.0 would yield a sample size of 6-10 subjects.  Using the Wilcoxon 
signed rank test, 14 subjects should allow for full saturation.  Descriptive statistics for all 
dependent variables were calculated.  Frequencies and proportions with 95% confidence 
intervals were calculated for all categorical variables (at risk for LEA, at risk for 
decreased hormonal profile (T, LH, Insulin, Leptin, Cortisol, IL-6).  A chi-square 
analysis was used to examine “at risk” for LEA.  A 2 (week) X 7 (days) ANOVA and 
paired T-tests assessed differences between the 2 training weeks and variables (e.g., EA, 
hormones, EEE, and EI).  Pearson’s correlation and regressions were used to examine 
relationships and predictive qualities between EA, secondary measures (DXA_BFP, 
RMR, EI, EEE, distance/mileage), and hormones (T, LH, Insulin, Leptin, Cortisol, and 
IL-6). 
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Results 
 Eighteen participants began the study, 3 were eliminated for lack of compliance 
with the required procedures of the study, and 1 dropped out due to fear of needles 
yielding a total of 14 participants.  Participants’ criterion demonstrated a VO2max 62.3 + 
6.9 ml/kg/min, FFM 65.7 + 5.4 kg, and a DXA_BFP 13.6 + 3.5%.  Ethnicity of 
participants demonstrated 7.1% Middle Eastern (n = 1), 14.3% African American (n = 2), 
and 78.6% Caucasian (n = 11).  Education levels revealed 92.9% (n = 13) had some level 
of college and higher. More specifically, 7.1% attained a clinical doctorate (n = 1), 35.7% 
attained a master’s degree (n = 5), 21.4% attained a bachelor’s degree (n = 3), 28.6% 
attained some level of college (n = 4), and 1 participant attained a GED (7.1%).   
Energy Assessment 
 Overall, when examining LEA using EEE from VO2max - HR regression and 
Garmin HRM, 32.1% (n = 9) of participants presented with LEA over the 2 training 
weeks (HV: 35.7%, n = 5; 28.6%, n = 4).  Using VO2max - HR regression EA, participants 
that presented at risk for LEA, demonstrated 47.1% (n = 8) (HV: 62.5%, n = 5; LV: 
33.3%, n = 3) had increased T levels (p = 0.04).  Of those participants with LEA, 26.1% 
(n = 6) (HV: 27.3%, n = 3; LV: 25%, n = 3) presented with low Leptin levels (p = 0.14).  
Using Garmin HRM EA, participants that presented at risk for LEA, demonstrated 41.2% 
(n = 7) (HV: 50%, n = 4; LV: 33.3%, n = 3) had increased T levels (p = 0.20).  Of those 
participants with LEA, 21.7% (n = 5) (HV: 18.2%, n = 2; LV: 25%, n = 3) presented with 
low Leptin levels (p = 0.01).  No other specific hormones presented with compromised 
levels due to LEA.   
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Energy Availability: All means and standard deviations for energy needs 
assessment data (e.g., RMR, EI, EE, EA etc.) can be found on Table 3.1.  A 2 (training 
conditions: HV, LV) x 7 (days) ANOVA and paired t-tests were used for examination of 
EA, EI, and EEE.  Paired t-tests demonstrated an average EA for both measurements: 1) 
EA_VO2max regression: 27.6 + 12.1 kcal/kg FFM·d  (HV: 25.2 + 12.9 kcal/kg 
FFM·d  and LV: 29.9 + 11.1 kcal/kg FFM·d ) (t(13) = -1.61, p = 0.13); and 2) EA_HRM: 
28.2 + 10.3 kcal/kg FFM·d  (HV: 26.9 + 9.6 kcal/kg FFM·d  and LV: 29.5 + 11.2 kcal/kg 
FFM·d ) (t(13) = -1.37, p = 0.15).  No significant differences were elicited between 
training weeks and EA.  Regarding both training weeks, examination in the specific daily 
account of LEA per week can be found in Table 3.1.     
 Energy Needs. One-way repeated-measures ANOVA (assumptions of sphericity 
were met due to only 2 weeks assessed) were calculated to compare difference across the 
2 training weeks for EI.  No significant effect was found between the 2 training weeks for 
EI.  Two measurements were used to assess EEE.  Due to missing data cells (determined 
by when participants exercised) an ANOVA was not used for EEE.  A paired samples t-
test was calculated to compare the mean of the 2 training weeks (HV and LV).  The mean 
of HV week using VO2max-HR regression was 1048.5 + 805.6 kcals and the mean for the 
LV week was 682.3 + 326.5 kcals.  No significant difference between the 2 training 
weeks (HV vs. LV) was elicited (t (13) = 1.7; p = 0.10).  The mean of HV week using 
Garmin HRM was 919.3 + 538.2 kcals and the mean for the LV week using Garmin 
HRM was 696.5 + 472.7 kcals.  A significant difference between the 2 training weeks 
(HV vs. LV) was elicited (t (13) = 3.5; p = 0.004).   
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Hormonal Profile 
Reproductive Hormones:  
Testosterone (T).  A paired samples t-test was calculated to compare the means 
between the 2 training weeks (HV and LV) for T with a mean of 1764.5 + 1598.2 ng/dL 
(T_HV: 1640.5 + 1385.3 ng/dL and T_LV: 1888.3 + 1831.1 ng/dL).  No significant 
differences were found between the 2 training weeks and T (t (13) = -1.53 p = 0.15).  
Testosterone presented high compared to normative male values (above 1070 ng/dL).  A 
Pearson correlation coefficient was calculated for the relationship between T and other 
variables (i.e., DXA_BFP, RMR, EI, EEE, etc.).  A strong negative correlation was found 
for overall T to RMR: (r (24) = -0.64, p < 0.001), a weak negative correlation was found 
for overall T to EI: (r (24) = -0.47, p = 0.02), as well as a strong positive correlation for 
overall T to DXA_BFP (r (24) = 0.83, p < 0.001). Significant associations were 
demonstrated between EA_VO2max Regression and overall T (χ (2) = 4.4, p = 0.04) and 
HV_T (χ (2) = 5.8, p = 0.02).    
 Two outliers were removed prior to regression analysis.  A simple linear 
regression was calculated to predict participant’s T levels based on their EA, RMR, EI, 
EEE, DXA_BFP, and distance.  Energy availability via 1) V02max-HR regression was not 
statistically a significant predictor of T levels (F (1,24) = 3.2, p = 0.09) with an R2 of 0.12 
or via 2) GarminHR (F (1, 24) = 3.8; p = 0.06) with an R2 of 0.14. A significant regression 
equation was found for T and RMR: (F (1, 23) = 16.23, p < 0.001), with an R2 of 0.4.  
Participants’ predicted T level is equal to 3123.5 ± -0.97 (RMR) ng/dL when RMR is 
measured in kcals.  Participants’ average T levels decreased -0.97 ng/dL for each kcal of 
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RMR.  A significant regression equation was also found for T and EI: (F (1, 24) =6.7, p = 
0.02), with an R2 of 0.22.  Participants’ predicted T level is equal to 2591.96 ± -0.44 (EI) 
ng/dL when EI is measured in kcals.  Participants’ average T levels decreased -0.44 
ng/dL for each kcal of EI.  A significant regression equation was found for T and 
DXA_BFP: (F (1,24) = 51.9, p < 0.001), with an R2 of 0.83.  Participants’ predicted T level 
is equal to -1273.5 ± 197.2 (DXA_BFP) ng/dL when DXA_BF is measured in kg.  
Participants’ average T levels increased by 197.2 ng/dL for each kg of DXA_BFP.  No 
other significant relationships were found for T (see Table 3.2).        
Luteinizing Hormone (LH). A paired samples t-test was calculated to compare the 
means between the 2 training weeks (HV and LV) for LH.  The mean for LH was 795.6 + 
313.9 pg/mL (LH_HV: 385.7 + 191.0 pg/mL and LH_LV: was 409.9 + 119.9 pg/mL).  
No significant differences were found between the 2 training weeks and LH (t (12) = -0.79, 
p = 0.44).  Luteinizing hormone did not present low compared to normative male values.  
A Pearson correlation coefficient was calculated for the relationship between LH and 
other variables (i.e., DXA_BFP, RMR, EI, EEE, etc.).  Non-significant weak correlations 
were found for all secondary measures (see Table 3.2).  Secondary measures (DXA_BFP, 
RMR, EI, EEE) and LH are not related. 
Four outliers were removed prior to regression analysis.  A simple linear 
regression was calculated to predict participant’s LH levels based on their EA, RMR, EI, 
EEE, and DXA_BFP.  The regression equation was not significant for EA via 1) V02max-
HR regression was (F (1,22) = 1.6, p = 0.22) with an R2 of 0.07 and via 2) GarminHR (F 
(1,22) = 0.47, p = 0.50) with an R2 of 0.02.  EA is not a significant predictor of LH levels.  
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No other significant predictors were found when examining RMR, EI, EEE, and 
DXA_BFP.   
Metabolic Hormones: 
 Insulin:  A paired samples t-test was calculated to compare the means between the 
2 training weeks (HV and LV) for Insulin with a mean of 7.7 + 2.6 mU/L (IN_HV: 7.1 + 
1.1 mU/L and IN_LV: 7.3 + 1.5 mU/L).  No significant differences were found between 
the 2 training weeks and T (t (13) = -1.10; p = 0.29).  Insulin presented within normative 
male values (< 25 mU/L) for both HV and LV weeks.  A Pearson correlation coefficient 
was calculated for the relationship between Insulin and other variables (i.e., BFP, RMR, 
EI, EEE, etc.) and no statistically significant relationships were found between Insulin 
and the other variables.  One outlier was removed prior to regression analysis.  A simple 
linear regression was calculated to predict participant’s Insulin levels based on their EA, 
RMR, EI, and DXA_BFP.  The regression equation was not significant for EA via 1) 
V02max-HR regression was (F (1,25) = 0.40, p = 0.53) with an R2 of 0.02 and via 2) 
Garmin_HR (F (1,25) = 0.29, p = 0.59) with an R2 of 0.01. Energy availability was not 
statistically a significant predictor of Insulin levels.   No significant predictors were found 
for Insulin.        
 Leptin.  A paired samples t-test was calculated to compare the means between the 
2 training weeks (HV and LV) for Leptin with a mean of 0.75 + 0.57 ng/dL (Lep_HV: 
0.82 + 0.59 ng/dL and Lep_LV: 0.68 + 0.58 ng/dL).  A significant difference was found 
between the 2 training weeks and Leptin (t (13) = 1.61 p < 0.001).  Within the HV week, 
78.6% (n = 11) of participants presented with low levels compared to normative male 
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values (between 1.2-9.5 ng/dL), while 85.7% (n = 12) presented with low leptin levels in 
the LV week.  A Pearson correlation coefficient was calculated for the relationship 
between Leptin and other variables (i.e., DXA_BFP, RMR, EI, EEE, etc.).  A strong 
negative correlation was found for overall LH to DXA_BFP: (r (24) = -0.73, p < 0.001).  
No other correlations were found. A significant association was demonstrated between 
Garmin HRM and overall Leptin (χ (2) = 6.4, p = 0.01) as well as HV_Leptin week (χ (2) 
=6.9, p = 0.01).    
 Two outliers were removed prior to regression analysis.  A simple linear 
regression was calculated to predict participant’s leptin levels based on their EA, RMR, 
EI, and DXA_BFP.  Energy availability was not statistically a significant predictor of 
leptin levels via 1) V02max-HR regression was (F (1,24) = 0.98, p = 0.33) with an R2 of 0.04 
and via 2) Garmin_HR (F (1,24) = 0.92, p = 0.35) with an R2 of 0.04.  A significant 
regression equation was found for Leptin and DXA_BFP: (F (1,24) = 27.18, p < 0.001), 
with an R2 of 0.51.  Participants’ predicted Leptin level is equal to -1.02 + 
0.13(DXA_BFP) ng/mL when DXA_BF is measured in kg.  Participants’ average leptin 
levels decreased by -1.02 ng/dL for each kg of DXA_BFP.  No other significant results 
were found for leptin.        
 Cortisol.  A paired samples t-test was calculated to compare the means between 
the 2 training weeks (HV and LV) for cortisol with a mean of 12.9 + 2.8 ug/dL 
(Cort_HV: 12.6 + 2.8 ug/dL and Cort_LV: 13.1 + 2.6 ug/dL).  No significant differences 
were found between the 2 training weeks and T (t (13) = -0.91 p = 0.38).  Cortisol 
presented within the normative range for males between 7-28 ug/dL.  A Pearson 
correlation coefficient was calculated for the relationship between Cortisol and other 
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variables (i.e., BFP, RMR, EI, EEE, etc.).  A weak negative correlation was found for 
overall Cortisol to Regression EEE (r (24) = -0.46, p = 0.01).  A simple linear regression 
was calculated to predict participant’s Cortisol levels based on their EA, RMR, EI, and 
DXA_BFP.  Energy availability was not statistically a significant predictor of Cortisol 
levels via 1) V02max-HR regression was (F (1,26) = 1.1, p = 0.30) with an R2 of 0.20 and via 
2) GarminHR (F (1,26) = 0.01, p = 0.92) with an R2 of 0.00.  A significant regression 
equation was found for Cortisol and V02max-HR RegressionEEE: (F (1, 26) = 7.07, p = 
0.01), with an R2 of 0.21.  Participants’ predicted Cortisol level is equal to 14.68 ± -0.002 
(EEE) ug/dL when EEE is measured in kcals.  Participants’ average Cortisol levels 
decreased -0.002 ug/dL for each kcal of EEE.  A significant regression equation was also 
found for Cortisol and DXA_BFP: (F (1, 26) = 12.0, p = 0.002), with an R2 of 0.32.  
Participants’ predicted Cortisol level is equal to 19.12 +-.46 (DXA_BFP) ug/dL when 
DXA_BFP is measured in percentage.  Participants’ average Cortisol levels decreased -
0.46 ug/dL for each percent of DXA_BFP.  No other significant relationships/predictors 
were found for Cortisol.        
 Interluekin-6 (IL-6). A paired samples t-test was calculated to compare the means 
between the 2 training weeks (HV and LV) for IL-6 with a mean of 0.68 + 0.60 pg/mL 
(IL-6_HV: 0.80 + 0.80 pg/mL and IL-6_LV: 0.56 + 0.39 pg/mL).  No significant 
differences were found between the 2 training weeks and IL-6 (t (13) = 0.95; p = 0.36).  
Interleukin-6 presented with most all the participants within the normal range (< 1.8 
pg/mL) with 1 participant above the normative male value.  A Pearson correlation 
coefficient was calculated for the relationship between IL-6 and other variables (i.e., 
BFP, RMR, EI, EEE, etc.). Weak correlations that were not significant were found for 
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DXA_BFP (r(25) = -0.4; p=0.84),  RMR (r(25) = -.15; p = 0.46), EI: (r(25) = -.25; p = 0.22), 
V02max-HR Regression EEE (r(25) = .02; p = 0.94), Garmin_HRM EEE (r(25) = -0.22; p = 
0.27), Distance (r(25) = -.23; p = 0.26).  These secondary measures (DXA_BFP, RMR, EI, 
EEE, and distance) are not related to IL-6 levels.  
 One outlier was removed prior to regression analysis.  A simple linear regression 
was calculated to predict participant’s IL-6 levels based on their EA, RMR, EI, and 
DXA_BFP.  Energy availability was not statistically a significant predictor of IL-6 levels 
via 1) V02max-HR regression was (F (1,25) = 0.94, p = 0.34) with an R2 of 0.04 and via 2) 
GarminHR (F (1,25) = 0.09, p = 0.77) with an R2 of 0.004.  No significant regression 
equation was found for IL-6 with the other measures (DXA_BFP, RMR, EI, EEE, 
Distance).  
 
Discussion  
 In this study we sought to find a relationship between EA and specific 
reproductive (T and LH) and metabolic hormones (Insulin, Leptin, Cortisol, and IL-6).  
Our overall results partially supported our hypothesis that LEA (< 20 kcal/kg FFM·d) 
would impact metabolic hormones, however, LEA only impacted Leptin.  Overall, 
participants presenting with LEA, 21.7% (n = 7) also presented with low levels of Leptin.  
Our participants did demonstrate increased levels of testosterone (47.1%, n = 8) in 
relation to LEA.  However, no other hormones were negatively impacted by LEA.  
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Energy Availability 
 Within this study, 2 separate training weeks (HV and LV) were used to examine 
energy needs and demands specific to EA and EEE.  To assess EA, we created a cutoff 
point for LEA at ≤ 20 kcal/kg FFM·d.  Our results yielded an average EA of 25.2 kcal/kg 
FFM·d (HV week) and 29.9 kcal/kg FFM·d (LV week).  There currently is no research 
examining free-living EA in males to compare our results with.  However, one study 
examining NCAA Division I female soccer players examining EA (LEA set at < 30 
kcal/kg FFM·d) demonstrated higher EA levels compared to our results (EA levels 
between 32 to 43 kcal/kg FFM·d for 3 measurements throughout the season).  While 
overall neither week demonstrated LEA (≤ 20 kcal/kg FFM·d) using VO2max - HR 
regression EA, 71.4% (n = 10) of the participants demonstrated LEA between 1 and 4 
days during both HV and LV weeks (see Table 3.1).  
Hormones 
 Overall, we did not see significant relationships between EA and the reproductive 
(LH) and metabolic (Insulin, Leptin, Cortisol, IL-6) hormones.  However, secondary 
measures (DXA_BFP, RMR, EI, and EEE) did demonstrate significant relationships 
between: 1) T and RMR, 2) T and EI, 3) T and DXA_BFP, 4) Leptin and DXA_BFP and 
5) Cortisol and EEE.  We were able to calculate a prediction equation from RMR, EI and 
DXA_BFP that all demonstrated significant regression equations to predict T levels in 
male endurance-trained athletes. Examining linear regressions, DXA_BFP was a good 
predictor for Leptin levels while EEE was a good predictor for Cortisol levels. This could 
be impactful for clinicians whom do not have access to blood testing capabilities.          
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Reproductive Hormones 
 Testosterone. Increases in T level were found with both weeks of training for our 
participants. More specifically, both weeks demonstrated larger values than the “normal” 
range of 270-1070 ng/dL.39 With the average for both weeks high (HV: 1640.6 + 1385.3 
ng/dL and LV: 1888.3 + 1831.1 ng/dL), this was not congruent with most of the literature 
examining endurance runners.  For example, previous research has demonstrated 
endurance training has a negative effect on testosterone levels in males.21 Additionally, 
resting testosterone levels were measured lower in endurance-trained males compared to 
untrained males.21 The mechanistic nature of this decrease is currently unknown.  One 
impression is that the decreased testosterone levels are related to dysfunctions in the 
hypothalamic-pituitary-testicular regulatory axis, which is congruent with literature 
within the female population.21 Presently, there is no existing literature that indicates any 
testosterone dysfunction is instigated by endurance training in males.21  
De Souza and colleagues44 established a “training volume-threshold” (~100 
km/week), which demonstrated significant changes in the male reproductive function.44 
High volume of endurance running (> 104 km/wk) showed associations with changes in 
both sex hormones profiles (decreased testosterone), and quality of semen (decreased 
mobility and increases in immature cell numbers).21,44 On average, our participants did 
meet this distance in the HV week but did not demonstrate decreases in T overall in either 
HV or LV week.  Peripheral and central mechanisms have been proposed as reasons for 
decreased testosterone.44 These proposed mechanisms for endurance runners include: 
peripheral mechanisms such as intrinsic failure of the tests to maintain steroid 
biosynthesis and altered hepatic clearance and metabolism of testosterone and central 
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mechanism include alterations in the hypothalamic and pituitary axes.44 As this study was 
observational in nature, energy deficiency (EA ~25-29 kcal/kg FFM·d) and body fat 
percentages (~13.5%) may not have been low enough, or EEE (~670 kcals)/mileage (~49 
miles; HV ~63 miles; LV: ~34) may not have been high enough, to elicit decreases in T 
levels. 
 Luteinizing Hormone.  Luteinizing hormone did not demonstrate a significant 
difference between the 2 weeks. Previous literature is in discordance regarding LH.  
Research has shown with increases in exercise, testosterone decreases; however LH has 
not shown to be significantly changed during these increases of training loads.22 
Conversely, Kuoppasalm et. al. 23 demonstrated that with long term, high intensity 
running, roughly 30 minutes after long-term runs, plasma LH significantly dropped 
below baseline levels by 42% (moderate run) and 45% (intense run).  Suggesting 
intensity of the exercise is important in regards to negative LH outcomes.23  
Female literature has shown hypothalamic gonadotropin-releasing hormone is 
common in female athletes (hypothalamic amenorrhea).24 Male literature examining male 
reproductive hormones (T and LH) have seen similar results as the female literature.  
MacConnie et. al.24 examined highly trained male marathon runners (125 – 200 
km/week) and found the runners had diminished frequency of spontaneous LH pulses and 
the amplitude of their LH pulses were decreased compared to healthy controls.24 These 
results suggest highly trained male athletes, akin to the female athlete, have deficiency of 
hypothalamic gonadotropin-releasing hormones.  Male studies examining military 
populations found similar results of decreased LH to distance runners.  Freidl et al.,14 and 
Kyrolainen et al.,18  examined military soldiers during active training camps who 
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presented with low LH levels during high training volume.  This may have been due to 
the sudden and dramatic increase in EEE and simultaneous dramatic decrease in EI. Our 
results found a strong negative correlation between LH and DXA_BFP, and previous 
literature may suggest a link with BFP and hormonal deficits14-16,45 
Metabolic Hormones 
 Insulin: Our results yielded “normal” ranges for Insulin across both training 
weeks with no statistically significant relationship to EA or other measures.  Our results 
are not congruent with previous literature that demonstrated decreases in insulin due to 
high EEE and low EI.14,18 Koehler et. al.,17 found decreases in insulin in relation to EA 
suppression (EA = 15 kcal/kg FFM·d) in male cyclists.  Previous research has 
demonstrated that when insulin is low or absent, glucose is not utilized as an energy 
source, and the body will begin to utilize fat as an energy source, consequently, insulin 
aids in the prevention of fat utilization for energy.25 Insulin aids in the regulation of 
amino acid uptake and has other anabolic effects throughout the body.25 Proposed 
mechanistic reasons for decreased insulin include a global effect on the hypothalamic-
pituitary axes3 or due to adaptations of glucose uptake in runners.25 It is suggested that in 
aerobically trained athletes, adaptations related to the increased blood flow 
(capillarization) causes augmented glucose disposal due to increased glucose transport 
proteins (GLUT 4) globally with less insulin required.46 More research is needed to 
understand the mechanism of decreased insulin in a LEA state.46  
 Leptin.  Overall, Leptin was the only hormone that demonstrated significant 
decreases compared to LEA and difference between the 2 training weeks (t(13) = 1.61 p < 
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0.001).   Our results found 78.6% (HV) and 85.7% (LV) of the participants presented 
with low leptin levels, which is congruent with Hagmar et. al.,15 who examined 18 
Olympic male athletes that participated in leanness sports and demonstrated low Leptin 
levels (1.04 ng/mL) as well as low DXA_BFP (11.7 + 3.4%) compared to non-lean 
sports.  Typically, body weight has an analogous relationship with leptin (i.e. weight loss 
reduces leptin while weight gain increases leptin levels).26 It is hypothesized that the 
reduction of leptin is an acute metabolic signal of starvation and energy conservation.26,27 
This is suggested due to the reductions in leptin are associated with the suppression of 
key endocrine axes (reproductive, growth hormone, IGF-I, and thyroid axes).27 During 
acute energy deficits, the rapid reduction of leptin is associated with changes in body 
composition.47     
 Cortisol.  Our results demonstrated our endurance-trained male athletes cortisol 
levels were within normal limits (7-28 ug/dL) means between the 2 training weeks (HV 
and LV) for cortisol with a mean of 12.9 + 2.8 ug/dL (Cort_HV: 12.6 + 2.8 ug/dL and 
Cort_LV: 13.1 + 2.6 ug/dL) with no differences between the 2 training weeks. However, 
we did find EEE and DXA_BFP was a good predictor of cortisol levels.  Cortisol also has 
the ability to suppress various systems including the reproductive and digestive system, 
as well as other growth process.28 Long-term triggering and overexposure to cortisol can 
disrupt bodily process and increase the risk to various health issues including, anxiety, 
depression, digestive issues, headaches, heart disease, sleep problems, and weight 
issues.28 Hill et. al.,28 demonstrated moderate to high intensity exercise invokes an 
increase in circulating cortisol levels, while in contrast; low intensity exercise (40% 
VO2max) decreases circulating levels.28 Cortisol levels may increase due to either an 
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increased need to catabolize other energy sources other than fat stores, or due to a 
reduction in clearance.14  
 Interleukin-6.  Our results demonstrated no differences between the 2 training 
weeks with a mean of 0.68 + 0.60 pg/mL (IL-6_HV: 0.80 + 0.80 pg/mL and IL-6_LV: 
0.56 + 0.39 pg/mL) or an increase in IL-6 levels compared to normative data (< 
1.8pg/mL).  This is not congruent with previous literature that found increases in IL-6 
levels after strenuous exercise as an inflammatory marker.48,49 However, this was 
reported as an acute response, while our blood draws were done after 24 hours of rest 
from exercise on the 8th day of the study.  Fischer50 examined IL-6 responses to acute and 
training loads, and found that there was a training effect for the down regulation of IL-6.  
This low plasma levels of IL-6 can be characterized as a training adaptation.50 This 
training effect, may explain our lower levels of IL-6. Research has also demonstrated 
glucose aids in decreased acute localized muscular release of IL-6.51 This mechanism of 
decreased IL-6 due to training or glucose needs to be examined as well as the inverse 
relationship, in the event of decreased EI and potential pathogenic dietary behaviors, 
which decrease carbohydrate ingestion in male athletes.   
 
Limitations and Future Directions  
 There were limitations identified in this study examining EA and hormones.  
First, an aspect of EA includes EI and EEE.  Energy intake was a 7-day self-reported 
dietary log but is most valid and reliable measurement compared to other self-reported 
food intake measurements (3-day and food frequency questionnaires.)52 Second, double- 
	  85 
labeled water would be a more valid and reliable examination of EEE was calculated 
using HRM and Vo2max-HR regression.  Double-labeled water would be a more 
accurate method to estimate EEE.  Additionally, data collection for the hormones was a 
one-time fasting blood draws on the morning on the 8th day.  However, some measures 
would have benefited from different measurements.  Specifically, LH is pulsatile in 
nature and would be better to examine LH multiple times.  Testosterone would have been 
more expressive if measured daily compared to one draw.  Another hormone, IL-6, has 
demonstrated more acute responses to exercise and may have given more information to 
inflammatory responses if measured within a few hours after exercise compared to after 
24 hours of rest at the end of the week.    Future studies should examine hormones to 
assess a more accurate assessment of LH, T and IL-6.  Also, an intervention study should 
be implemented examining specific EA levels and the response of reproductive and 
metabolic hormones specific to set EA levels.  
 
Conclusions 
 Overall, LEA demonstrated a relationship with Leptin.  Other variables BFP, 
RMR, EI and EEE also demonstrated relationships with T, Leptin and Cortisol.  The 
implications of these relationships, speaks to the physiological influence of EA, EI, EEE 
and body composition on hormones.  This knowledge is impactful for general knowledge 
of clinicians regarding the hormonal profile of male athletes, especially those with 
decreased EA, EI, and BFP, and increased EEE.  Male runners should monitor their EEE 
and EI to maintain appropriate levels of EA; which currently we have evidence to suggest 
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above 20 kcal/kg FFM·d due to altered hormonal response of Leptin.  Valid and reliable 
predictive equations for hormones (T, Leptin, Cortisol) may become useful tools for 
clinicians whom do not have access to blood work.     
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TABLES 
Table 3.1:  Energy need assessments for Endurance Trained Male Athletes (n=14). 
Values are presented in Mean ± Standard Deviation. 
  ALL 
  M SD 
Energy Needs Assessment    
 Resting Metabolic Rate (kcals)  1799.3 549.0 
 Energy Intake (kcals)  2658.9 230.4 
 Exercise Energy Expenditure (kcals)-
GHR 
 636.7 127.1 
 Exercise Energy Expenditure (kcals)-
VO2 
 865.4 566.1 
 Energy Availability (kcal/kg FFM·d )-
GHR* 
 28.2 10.4 
 Energy Availability (kcal/kg FFM·d )-
VO2* 
 27.6 12.0 
      
Low Energy Availability Risk  HV% N LV%  N 
 LEA ≤ 2 days per week-GHR  42.8 6 35.7 5 
 LEA 3-4 days per week-GHR  21.4 3 21.4 3 
       
 LEA ≤ 2 days per week-VO2  35.7 5 50.0 7 
 LEA 3-4 days per week-VO2  35.7 5 21.4 3 
       
 LEA ≤ 2 days per week-Arm  35.7 5 21.4 3 
 LEA 3-4 days per week-Arm  21.4 3 28.6 4 
 LEA 5-6 days per week-Arm  21.4 3 21.4 3 
 LEA 7 days per week-Arm  7.7 1 7.7 1 
*Note: LEA for the week was calculated by taking the average of the 7 days of EA. 
LEA = low energy availability; GHR = Garmin Heart Rate Monitor; VO2=VO2max-
HR Regression; Arm=Armband.  EEE- calculated by average number of days of 
exercise per week across individuals.   
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Table 3.2: Hormonal Profile for Endurance Trained Male Athletes (n=14).  
Data is presented in mean (M) and standard deviation (SD). 
 Overall HV Week LV Week 
 Mean SD Mean SD Mean SD 
Reproductive       
 Testosterone 
ng/dL 
1764.5 1608.2 1640.6 1385.3 1888.3 1831.1 
 Luteinizing 
Hormone 
pg/mL  
398.8 155.5 385.7 191.0 409.9 119.9 
        
Metabolic       
 Insulin mU/L 7.25 1.23 7.15 1.07 7.34 1.46 
 Leptin ng/dL 0.63 0.38 0.82 0.59 0.68 0.58 
 Cortisol ug/dL 12.92 2.78 12.63 2.75 13.11 2.61 
 Interleukin-6 
pg/mL 
0.68 0.60 0.80 0.80 0.56 0.39 
*Note: Hormones were collected on the 8th day after 24 hours of rest.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	  
 
93 
FIGURES 
Figure 3.1: Testosterone levels as a function of Resting Metabolic Rate in endurance-
trained male runners.  Testosterone measured ng/dL and RMR measured in kcals; (r (26) = 
-0.64, p < 0.001). A significant regression equation was found (F (1,23) = 16.23, p < 
0.001), with an R2 of 0.4. 
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Figure 3.2: Testosterone levels as a function of Energy Intake in endurance-trained male 
runners.  Testosterone measured ng/dL and EI measured in kcals, n = 26; (r (24) = -0.47, p 
= 0.02).  A significant regression equation was found (F (1, 24) = 6.7, p = 0.02), with an R2 
of 0.22. 
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Figure 3.3:  Testosterone levels as a function of Body fat percentage in endurance-
trained male runners.  Testosterone measured ng/dL and DXABFP measured in 
percentage (%); (r (24) = 0.83, p < 0.001). 
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Figure 3.4: Leptin levels as a function of Body Fat Percentage in endurance-trained male 
runners.  Leptin measured ng/dL and DXABFP measured in percentage (%); (r (24) = -
0.73, p < 0.001).  A significant regression equation was (F (1,24) = 27.18, p < 0.001), R2 of 
0.51. 
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Figure 3.5: Cortisol levels as a function of V02max-HR Regression Exercise Energy 
Expenditure in endurance-trained male runners.  Cortisol measured ug/dL and EEE 
measured in kcals; (r (24) = -0.46, p = 0.01).  A significant regression equation was found 
(F (1, 26) = 7.07, p = 0.01), R2 of 0.21.   
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CHAPTER 4 
REVIEW OF LITERATURE 
Endurance athletes an at-risk population 
Endurance athletes are unique due to the physiological demands of their high-
energy expenditure sport participation. These increased psychological demands increase 
endurance athletes’ (e.g. distance runners) risk of impaired physiological functions.1-9 
Endurance athletes are exposed to an increased risk of injuries and illnesses compared to 
other sports.  Specifically examining injuries in endurance runners; due to the repetitive 
impact forces, stress fractures are more common in distance runners than other endurance 
athletes.10 The NCAA estimates the incidence of stress fractures range from 1% - 2.6% in 
all athletes compared to 15% in runners.10 A 10 year retrospective review highlighted 
NCAA Division I college distance runners suffered most stress fractures of all male and 
female athletes.10 Current research suggests differences in loading forces and the high-
energy expenditure bone health of endurance runners is inferior to other sport athletes.   
Endurance athletes are also exposed to increased risks of illness.10 Hagmar et. 
al.,11 confirmed more lean Olympic athletes reported being ill during a 3month period 
prior to competition compared to non-lean athletes (38.5% vs 21.6%, P < 0.05)11 and had 
specifically higher frequencies of mild diseases including upper respiratory tract 
infections.11,12 Another illness specific to endurance athletes includes potential adverse
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cardiovascular effects.13 Emerging data has shown long-term excessive endurance 
exercise (marathons, ultramarthons, ironman distance triathlons, and distant bicycle 
races) has associations with coronary artery calcification, diastolic dysfunction and artery 
wall stiffening, and sudden cardiac death (SCD).13 While long-term excessive exercise 
may cause adverse cardiovascular remolding, further investigation is still needed at this 
time to understand mechanistic causes.13 Rates for SCD are rare, 1 SCD/100,000 
participants (.00001).13 However, while the risk of SCD has not increased, the absolute 
rates for mortality of SCD has increased as annual participation in marathons have 
increased 20-fold.13     
Most link negative body image issues to females only; however, literature has 
shown this is tenuous.  Mellor et al.14 confirmed an inverse relationship in adult men 
between self-esteem and body image.  Unique results of this study reported men, when 
compared to women, place greater importance on their appearance and described high 
levels of body dissatisfaction.14 Hagmar and colleagues11,12  have examined male 
Olympic athletes and the differences between leanness and non-leanness sports. Male 
athletes in leanness sports reported lower BMI (22.7 ± 2.7 kg/m2 vs 23.7 ± 2.3 kg/m2 for 
non-lean athletes, P < 0.05) and greater variations in weight (5.3% vs 4.7%, P < 0.05) 
compared to non-lean athletes.11 Lean athletes also reported more frequent attempts of 
weight loss (P < 0.001) as well as reporting longer training times and more pronounced 
training loads (P < 0.001).11 Significant differences were discovered between male 
Olympic leanness and non-leanness athletes when examining body composition.11,12 
Leanness athletes exhibited a total body fat and total body fat percentage significantly 
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lower when compared to non-leanness athletes (leanness 9.2+3.5 kg, 11.7% + 3.4; non-
leanness 13.2 + 5.3 kg, 16.4 + 5.8%).11,12 
 
Relative Energy Deficit in Sports (RED-S) 
In 2014, the International Olympic Committee (IOC) issued a Consensus 
Statement, “Beyond the Female Athlete Triad: Relative Energy Deficiency in Sport 
(RED-S)”.7 This new paradigm addresses energy deficiency in sports for all types of 
athletes, including females, males, and non-able bodied (e.g. Para-Olympic athletes). 7   
This syndrome of RED-S, designed to be all encompassing model, highlights 
physiological impairments to the athlete resulting from relative energy deficiency. 7  
These impairments comprise various physiological systems including: cardiovascular 
health, bone health, menstrual function, immunity, protein synthesis, and metabolic rate. 7  
While the IOC’s RED-S is lacking empirical literature to illustrate RED-S as an 
encompassing model, it does provide awareness and the necessity to examine other 
populations (males and non-able bodied athletes).7 Current literature examining men, 
have shown similar physiological decrements to the Female Athlete Triad (Triad), 
compromising of compromised reproductive hormones,15-20 decreased bone mineral 
density,10,21,22 and negative energy deficiency11,12,18,23.  Currently the only research 
specifically examining low energy availability (LEA) in the male population was Koehler 
et. al.,18 in 2016, after the issuance from the IOC. 
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Energy Balance vs. Energy Availability  
Energy balance (EB), as defined in the field of dietetics, is the dietary energy 
intake (EI) minus the total energy expenditure (EB= EI-TEE).5 Specifically, this is the 
amount of dietary energy, either auxiliary or used from the body’s overall energy stores 
once all physiological systems have completed their energy expenditure demands for the 
day.5 Energy balance is measured as an output from those systems, and categorized when 
EB=0 kcal/day.5 Energy availability (EA) is defined as the dietary EI minus the energy 
expended in exercise (EA=EI-EEE).5 Energy availability is the dietary energy residual 
after exercise training for all other physiological and metabolic processes.5 Energy 
availability is an input to the physiological systems and categorized at a healthy status of 
EA=45 kcal/kg FFM·d. 5 
The disparity amongst EB and EA is that an athlete can have low energy 
availability (LEA) but maintain their EB.  This is due to the suppression of various 
physiological processes due to the lack of EA.5 Strubbs et. al.,23 provided an example of 
the contrast between EB and EA.  Eight lean men had a suppressed caloric energy intake 
and an increased exercise energy expenditure resulting in a constant energy availability of 
30 kcal/kg FFM·d.23 Strubbs et. al.,23 found the negative energy balance decreased 
towards zero at a rate of 90kcal/day due to the decreased physiological processes, and 
estimated three weeks for participants to elicit an EB of zero while stilling remaining in a 
severely LEA state.23 Due to EB being an output from of physiological systems it is does 
not provide the most reliable information in regards to energy requirements of athletes, 
therefore is not the most useful in managing energy.5 
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Energy Availability  
 Koehler et. al.,18 is the first study to examine short-term energy availability 
reduction in exercising men.  Similar to Loucks et. al.,24,25 examination in females; 
Koehler et. al.,18 reduced EA to 15 kcal/kg FFM·d in six exercising men.  This reduction 
of EA resulted in a significant suppression of leptin and insulin hormones.  Koehler et. 
al.,18 found a decreasing trend in the hormone testosterone.18 Other research has 
examined chronic energy deficits and its effect on various hormones and bone mineral 
density.11,12,16-19,23,26 However, EA was not calculated or examined specifically.  To date, 
there are no established LEA markers for the male athlete. 
Energy availability markers for female athletes have been established at 45 
kcal/kg FFM·d.1-9 Literature has established this is due to significant physiological 
changes, which occur at and below 30 kcal/kg FFM·d.3-6,9,25 These physiological changes 
include: metabolic rate declines, bone reabsorption increases, protein synthesis 
breakdown occurs at this level, and reproductive hormones (i.e.. LH, FSH, and estrodral) 
decrease.1-6,9 In the female literature, LEA is the catalyst for Triad symptoms. The 
American College of Sports Medicine (ACSM)26 has identified 3 categories describing 
the origins of energy deficiency in athletes; (1) lack of knowledge of energy needs based 
on demands of the energy expended, (2) clinical eating disorders and (3) intentional 
subclinical mismanagement of energy consumption to reduce body size and fatness.26 
This could include disordered eating behaviors similar to various eating disorders such as 
fasting and purging.26 Previously established research has examined and recognized the 
physiological differences in males and females, prompting De Souza et. al.,2 in response 
to the IOC’s REDs model, to stress the necessity to establish independent clinical 
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guidelines in regards to energy deficiency and the physiological impacts specifically for 
males and females.   
 
Female Athlete Triad 
The Female Athlete Triad has a strong empirical literature foundation 
encompassing thirty years of literature on the female athlete and the effects of reduced 
EA.  The Triad is defined, from the “2014 Female Athlete Triad Coalition Consensus 
Statement on Treatment and Return to Play of the Female Athlete Triad”1, as a medical 
condition observed in physically active girls and women involving 3 components: (1) low 
energy availability with or without disorder eating, (2) menstrual dysfunction, and (3) 
low bone mineral density.1 In 2007, the Triad conceptually changed from a triangle 
model (disordered eating, amenorrhea, and osteoporosis) into a 3 interrelated spectrum 
describing the Triad as a syndrome of LEA with or without DE/ED, functional 
hypothalamic amenorrhea, and compromised BMD.8 This spectrum model allows for the 
early recognition of subclinical abnormalities and early intervention for at risk female 
athletes.1 Health consequences associated with the Triad range a spectrum of systems 
within the body including; endocrine, gastrointestinal, renal, neuro-psychiatric,  
musculoskeletal and cardiovascular health. 1 
 
Triad-Like Symptoms in Males 
Trends have been established in previous literature in males expressing Triad like 
symptoms.  When EA is compromised, various gonadal and reproductive hormones are 
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suppressed,15-20 BMD is reduced,15,16,21,22 and limited research has described a prevalence 
of disorder eating ranging from 10%-42% in male athletes.11,12,27 
Military research has shown male soldiers during occupational missions are 
exposed to dietary restrictions causing decreased EA.  Fridel et. al.,17 examined US Army 
Rangers during their 8-week Ranger Course.  During these 8 weeks; 4 cycles of restricted 
energy intakes (EI) and refeeding, incorporating EI deficits of 1,000-1,200 kcal/day 
occurred.17 Research has revealed that due to deficits in EA in males, gonadal and 
reproductive hormones (testosterone (T), thyroid, Sex hormone-binding globulin, and 
insulin-like growth factor I(IGF-I)) were reliable hormonal markers when assessing acute 
energy deficits.17 Cortisol and cholesterol were specific hormonal markers, which 
assessed the chronic state of energy deficits in the male US Army Rangers.17 
Congruently, Kryolainen et. al.19 examined hormonal alterations during prolonged 
military field exercises in Finnish soldiers and the effect of various energy deficits 
prompted through exercise intensity.  Kryolainen et. al.19 found during an average energy 
deficit of 4,000 kcal/day in phase I of training (one week long) significant increases in 
cortisol (+32%) and growth hormone (+616%) where exhibited while insulin (-70%), 
total T (-27%) and free T (-26%) decreased.  Once energy deficits were reduced 
(<1,000kcal/day in Phases II and III), all hormonal markers stabilized.19    
Research examining endurance sports (running, biking, and swimming) have been 
found to have lower BMD than athletes participating in other sports and even lower than 
inactive peers.  Hetland et. al.,28 demonstrated lumbar spine BMD was negatively 
correlated to average weekly mileage for distant runners.  Dolan et. al.,15,16 demonstrated 
professional jockeys had reduced bone mass and an elevated rate of bone loss due to a 
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disruption in hormone activity in response to chronic weight cycling.  Research has 
revealed 25%-63% of male cyclists were diagnosed with osteopenia, while 9% were 
diagnosed with osteoporosis.21,22 
Previous research has shown women are more at risk for eating disorders 
(ED)/disorder eating (DE) compared to males, however literature has shown males 
especially in lean sports have increased risks of similar energy restriction behavior and 
similar associated negative physiological responses.   Martensen et. al.,27 found 
prevalence in male athletes to range from 10% to 42%, for DE behaviors.  In male 
Olympic athletes, Hagmar and colleagues12 observed participants who were categorized 
within “lean sports” had significantly lower body fat proportions, lower free T, leptin 
levels, and an increase in IGF-I. 12 
 
Eating Disorders/Disorder Eating:   
Currently research examining ED risks in male athletes are inconclusive.  It is 
evident ED risks are higher in females than males; however, the rate of males are 
becoming more prevalent in literature. Rates range from 10%-42% for disordered eating 
prevalence.27 Similar to female literature, there are increased ED risks associated with 
specific sports such as weight class sports (e.g. wrestling, rowing, Judo).11,12,27 Rosendahl 
et. al.,29 examined Elite Sports School, an elite high school for athletes, and found boys in 
leanness sports had a twofold higher frequency of DE compared to non-leanness athletes 
(risk ratio = 2.11, 95% CI 1.11-4.04).29 While female literature has examined a larger 
variety of female athletes and sports, there is limited research examining males across a 
variety of sports.29 
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Assessment measurements (instrumentation and questionnaires) used to assess the 
risk of disordered eating in males needs to be more congruent to address males at risk.29 
While dieting is linked to mostly the female population, male athletes were most 
frequently dieting to enhance performance.29 One third of the male athletes were dieting 
because a coach or teacher pressured them.29 Within the leanness male athletes, 13% 
were dieting while 6% were using pathogenic weight control measures compared to 11% 
dieting and 5% pathogenic weight control measures in the non-leanness sports.29 
Disordered-eating symptoms among adult elite athletes have previously been under 
reported.29 However, predictors associated with symptoms of DE among both female and 
male athletes were found to be body mass index (BMI) and gender (p<0.001 and 
p=0.012).29 
The DSM-5 characterizes feeding and eating disorders as a consistent disruption 
in eating-related behavior which results in altered or compromised intake of food that has 
significant impairment on the physical and mental health of the eater.30 The DSM-5 
addresses diagnostic criteria for six specific feeding and eating disorders; pica, 
rumination, avoidant/restrictive food intake disorder, anorexia nervosa, bulimia nervosa, 
and binge eating disorder. 30 
 
Pica  
 Pica is defined as the persistent eating of nonnutritive, nonfood substances over a 
minimum period of one month, which includes substances that are inappropriate to the 
development level of the individual and not culturally or socially normative practices.30   
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Pica can occur within the context of another mental disorder (e.g. autism spectrum 
disorder, schizophrenia, intellectual disability) and other medical conditions such as 
pregnancy, which would warrant additional clinical attention.30   
 
Rumination   
Rumination is characterized as the repeated regurgitation, re-chewed, re-
swallowed, or spit out, of food over a one-month period. 30 Regurgitation is not associated 
with gastrointestinal medical conditions such as gastroesophagela reflux and pyloric 
stenosis.30 Rumination could occur concurrently but not exclusively with anorexia 
nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake 
disorders.30 Rumination disorder can present with concurrent symptoms with another 
mental disorder (e.g. intellectual disability, another neurodevelopmental disorder, and 
generalized anxiety disorder), which may warrant additional clinical attention.30     
 
Avoidant/Restrictive Food Intake Disorders 
Avoidant/restrictive food intake disorders is described as an eating or feeding 
disturbance based on the sensory characteristics of food; concern about adverse 
consequences of eating manifested by persistent failure to meet appropriate nutritional 
and/or energy needs associated with one or more of the following: (1) significant weight 
loss, (2) significant nutritional deficiency, (3) dependence on enteral feeding or oral 
nutritional supplements, (4) marked interference with psychosocial functioning.30 The 
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disturbance in energy intake is not explained by lack of available food or associated 
culturally sanctioned practices.30 Avoidant/restrictive food intake disorders can 
concurrently or non-exclusively occur with anorexia nervosa or bulimia nervosa. 30   
However, with avoidant restrictive food intake disorder, there is no associated concurrent 
medical condition or mental disorder.30 
 
Anorexia Nervosa  
Anorexia Nervosa is the restriction of energy intake relative to requirements 
leading to a significantly low body weight in context of age, sex, developmental 
trajectory and physical health.30 Significantly low body weight is determined as a weight 
less than minimally normal.  Anorexia nervosa is associated intense fear of gaining 
weight or becoming fat or a persistent behavior that interferes with weight gain despite 
having low body weight.30 The disturbance alters body weight or shape and a persistent 
lack of recognition of the seriousness of the low body weight.30 There are 2 subtypes: 
restricting and binge-eating/purging type categorized with Anorexia Nervosa.30 
Restricting type is defined for an individual, over the course of 3 consecutive months, has 
not participated in binge eating or purging behaviors (e.g., vomiting, laxatives, enemas, 
and diuretics).30 Binge-eating/purging behaviors are described as an individual engaging 
in recurrent episodes of binge eating or purging behaviors (e.g., vomiting, laxatives, 
enemas, and diuretics) over the course of 3 consecutive months.30           
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Bulimia Nervosa 
Bulimia Nervosa is characterized as recurrent episodes of binge eating, eating in a 
discrete period of time (e/g within any 2 hour period), larger than normal amounts of food 
in that most individuals would eat in a similar time frame.30 This is also accompanied by 
a lack of control during the eating episode.30 Inappropriate compensatory behaviors to 
prevent weight gain are accompanied with the recurrent binging eating.30 These behaviors 
include self-induced vomiting, misuse of laxatives, diuretics, and other medications, 
fasting, or excessive exercise.30 Occurrence of the binge eating and inappropriate 
compensatory behaviors occur concurrently on average at least once per week for 3 
consecutive months.30 The eating/purging disturbances do not exclusively occur during 
episodes of anorexia nervosa, and self-evaluation is unduly influenced by body shape and 
weight.30      
 
Binge-Eating Disorder 
Binge-Eating Disorder is defined as recurrent episodes of binge eating 
characterized by 2 components; eating a larger amount of food in a discrete time period, 
which is more than most people would eat in a similar time period under similar 
circumstances and a lack of control over eating during the episode.30 Binge episodes are 
linked with 1 or more of the following behaviors: eating more rapidly than normal, eating 
until uncomfortably full, eating large amounts of food without physical hunger, eating 
alone due to embarrassment over the amount of food one’s consumed, and negative 
feelings of disgust, depression or guilt after consuming food.30 Binge eating is classified 
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as a minimum of 1 binge per week for 3 consecutive months.30 Binge eaters are distressed 
regarding behavior, and the behavior is not concurrently associated with bulimia nervosa 
or anorexia nervosa.30    
 
Prevalence of Eating Disorders in Males   
 Prevalence of eating disorders (ED) in male athletes has been lacking in the 
literature when compared to female athlete literature.  Previous research has 
demonstrated 73.6% of all elite athletes meet at least one criterion for diagnosing an 
eating disorder.31 Roughly one million males present with an ED, however researchers 
believe this is a gross underestimation due to under-reporting and males being less likely 
report EDs or seek diagnosis/treatment.32 Research has estimated 5% of elite male 
athletes present with anorexia nervosa or bulimia nervosa32 and another 1% of males 
represent “other specified feeding or eating disorders.33 Norwegian researchers found 
13.5% of both male and female athletes were diagnosed with a clinical and/or subclinical 
ED.34 When compared to non-athletes (4.6%), this was twice as high for the athletes.34 
Sundgot-Borgen et. al.34 also demonstrated endurance athletes presented with 9% 
diagnosed ED, which was higher than ball-game athletes with 5% diagnosed ED.  
 There is limited research examining specific eating disorders prevalence in male 
athletes.  Rates in males are currently unknown for anorexia nervosa, however an 
estimated 10:1 ratio has been demonstrated for females to males.30 Male rates for bulimia 
nervosa is currently unknown; however female rates are estimated between 1%-1.5%.30 
Binge eating rates for males are estimated at 0.8%.30 Rates are presently unknown across 
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ethnicity and race.30 Binge eating and anorexia nervosa are the two most common eating 
disorders in athletes.31 The National Institute of Mental Health reports roughly 5%-15% 
of males present with anorexia or bulimia.35 Other ED rates are unknown; Pica is usually 
seen in children and rumination is often seen in infants between the ages of 3-13 months 
of age.30   
 Males also present with pathogenic eating behaviors, similar to females.  
Research suggests 37% of male athletes (age 18-22) exercise 2 or more hours per day for 
the purposeful intention to burn calories.36 Males demonstrated engagement in restrictive 
diets at least twice in 1 calendar year.36 This may be due to a distorted self-image where 
males observe that their BMI is larger than their actual BMI.37 Research presents 
inconclusive motives for pathogenic behaviors for males currently.  Roughly half of male 
research presents with concurrent EDs and body dissatisfaction or with EDs without body 
dissatisfaction.38 Similar to the female literature, elite male athletes participating in sports 
that require leanness shows increases in ED risk.33 However, to date the literature focused 
on ED is limited and there is not the ability to compare male athletes to other male 
control groups.33      
 
Bone Mineral Density  
Literature suggests endurance athletes have decreased BMD compared to other 
athletes.  Scofield and Hecht39 examined endurance runners, and found runners had 
consistently lower BMD when compared with sprinters, gymnasts and ball sports 
athletes.39 When endurance runners were examined with other runners (sprinters), cortical 
density was inversely related to competitive distance, with the lowest cortical density 
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elicited with long distance running.40 Taafee and colleagues41  examined distance runners 
and confirmed a reduction in BMD over time compared to cross-sectional studies.41 
Other research examining other endurance sports has revealed increased risks of 
osteopenia, and osteoporosis in cyclists and swimmers.12,20,22,39 Dolan et. al.,15,16 
examined professional horse jockeys and found not only reduced bone mass but an 
elevation in the rate of bone loss.  Endurance running is a weight-bearing sport that 
requires high metabolic demands; energy availability may be a critical role in long-term 
bone health.40 
 
Hormones 
 Existing literature has established long periods of restricted energy intake or rapid 
weight loss in male athletes have affiliation to negative hormonal effects.11,12,15-19,23 Many 
researchers believe T levels create a protective mechanism that shields men from similar 
components of the Triad found in women.  Previous research has demonstrated various 
negative hormone effects when energy deficits occur.15-17,19 Gonadal and reproductive 
hormones; T, sex hormone-binding globulin, thyroid hormones, and IGF-I, cholesterol, 
and cortisol have been reliable markers in assessing energy deficits in males.11,12,15-19,23 
Koehler et. al.,18 is the only existing literature to date to examine short-term energy 
availability reduction in exercising men.  Energy availability was reduced to 15 kcal/kg 
FFM·d resulting in the suppressions of leptin and insulin.18 A trend was found in the 
decrease in T.18 Reasons for this incongruence to the previous literature could be due to 
the 4 days of energy restriction or to the limited size of the participants (n=6).18     
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Reproductive Hormones  
Testosterone 
Testosterone (T) is a steroid hormone produced in the testes (specific for males) 
and adrenal cortex.42 Testosterone stimulates development of male secondary sexual 
characteristics.42   Research has demonstrated endurance training has a negative effect on 
testosterone levels in males.43 Resting testosterone levels were measured lower in 
endurance-trained males compared to untrained males.43 The mechanistic nature of this 
decrease is currently unknown.  Research directs to one impression, that the decreased 
testosterone levels are related to dysfunctions in the hypothalamic-pituitary-testicular 
regulatory axis, which is congruent with literature within the female population.43 
Presently, there is no existing literature that indicates any testosterone dysfunction is 
instigated by endurance training in males.43 De Souza and colleagues44 established a 
“training volume-threshold” (~100km/week), which has significant changes in the male 
reproductive function.44 High volume of endurance running (>104 km/wk) showed 
associations with changes in both sex hormones profiles (decreased testosterone), and 
quality of semen (decreased mobility and increases in immature cell numbers).43,44 
Peripheral and central mechanisms have been proposed as reasons for decreased 
testosterone.44 These proposed mechanisms for endurance runners include: peripheral 
mechanisms such as intrinsic failure of the tests to maintain steroid biosynthesis and 
altered hepatic clearance and metabolism of testosterone and central mechanism include 
alterations in the hypothalamic and pituitary axes.44 
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Luteinizing Hormone 
 Luteinizing Hormone (LH) in males stimulates the production of testosterone and 
in part, aids in the role of sperm production.45 Research has shown that with increases in 
exercise testosterone decreases; however LH has not shown to be significantly changed 
during these increases of training loads.45 Conversely, Kuoppasalm et. al. 46 showed that 
with long term and high intensity running, roughly 30 minutes after long-term runs, 
plasma LH significantly dropped below baseline levels by 42% (moderate run) and 45% 
(intense run).  Suggesting intensity of the exercise is important in regards to negative 
outcomes.46 Female literature has shown hypothalamic gonadotropin-releasing hormone 
is common in female athletes (hypothalamic amenorrhea).47 MacConnie et. al.47 
examined highly trained male marathon runners (125-200km/week mileage) and found 
the runners had diminished frequency of spontaneous LH pulses and the amplitude of 
their LH pulses were decreased compared to healthy controls.47 These results suggest 
highly trained male athletes, akin to the female athlete, have deficiency of hypothalamic 
gonadotropin-releasing hormone.  It is hypothesized that due to repetitive elevations of 
other hormones, which, suppress gonadotropin-releasing hormone, are related to daily 
training.47  
 
Metabolism 
Insulin  
 Insulin is a peptide hormone and produced from Beta cells within the islets of 
Langerhans in the pancreas and contributes an important role in metabolism.48 Insulin 
aids in the absorption of glucose into muscle, fat, and liver cells for energy.48 Insulin also 
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stimulates muscle and liver tissue to store excess glucose in the form of glycogen, in turn 
suppressing gluconeogenesis by the liver.48 When insulin is low or absent, glucose is not 
utilized as an energy source, and the body will begin to utilize fat as an energy source, 
consequently, insulin aids in the prevention of fat utilization for energy.48 Insulin aids in 
the regulation of amino acid uptake and has other anabolic effects throughout the body.48 
Proposed mechanistic reasons for decreased insulin include a global effect on the 
hypothalamic-pituitary axes3 or due to adaptations of glucose uptake in runners.48 It is 
suggested that in aerobically trained athletes, adaptations related to the increased blood 
flow (capillarization) causes augmented glucose disposal due to increased glucose 
transport proteins (GLUT 4) globally with less insulin required.49 More research is 
needed to understand the mechanism of decreased insulin in a LEA state.49  
 
Insulin-Like Growth Factor I 
 Insulin-like Growth Factor-I (IGF-I) is a polypeptide derived from the liver that 
plays an important role in the intervention of metabolic and anabolic cellular responses 
during altered energy states.50 Changes in body composition, negative energy balance and 
protein-energy malnutrition all effect IGF-I.50 Other processes IGF-I contributes vital 
roles for includes stimulating protein synthesis and maintaining muscle mass.50 Previous 
research found IFG-I correlated significantly with relative body mass loss and fat-free 
mass loss.51 Nindl et. al.,51 examined the IGF-I system and found all components were 
directionally associated with the decrease of energy deficits and losses of body mass. 51 
However, more research is needed prior to using IFG-I system as a predicative ability as 
a biomarker.51 
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Metabolic  
Leptin  
 Leptin is an adipoocytokine hormone that affects neurons in the hypothalamus 
responsible for the regulation of body mass loss and satiety regulating dietary energy 
intake and energy expenditure.52 Through the sympathetic and direct induced increase of 
fatty acid disposal in metabolism.52 Leptin stimulates appetite suppression and reduces 
the level of brain chemicals that stimulate appetite.52 Leptin receptors have various 
actions due in large part to the numerous types of tissues that contain leptin receptors.52 
Most prominent tissues include the skeletal muscle and the liver.52 Typically, body 
weight has an analogous relationship with leptin (i.e. weight loss reduces leptin while 
weight gain increases leptin levels).52 It is hypothesized that the reduction of leptin is an 
acute metabolic signal of starvation and energy conservation.52,53 This is suggested due to 
the reductions in leptin are associated with the suppression of key endocrine axes 
(reproductive, growth hormone, IGF-I, and thyroid axes).53 During acute energy deficits, 
the rapid reduction of leptin is associated with changes in body composition.54     
 
Cortisol  
 Cortisol is the primary hormone related to stress (physical, psychological and 
physiological) and is a glucocorticoid hormone from the adrenal cortex.55 Cortisol has 
various roles in the body including increasing glucose up regulation into the bloodstream 
and brain, inhibits nonessential functions that would be detrimental in a “flight-or fight” 
state, and alters the immune system response.55 Cortisol also has the ability to suppress 
various systems including the reproductive and digestive system, as well as other growth 
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process.55 Long-term triggering and overexposure to cortisol can disrupt bodily process 
and increase the risk to various health issues including, anxiety, depression, digestive 
issues, headaches, heart disease, sleep problems, and weight issues.55 Hill et. al.,55 
demonstrated moderate to high intensity exercise invokes an increase in circulating 
cortisol levels, while in contrast; low intensity exercise (40% VO2max) decreases 
circulating levels.55 Cortisol levels may increase due to either an increased need to 
catabolize other energy sources other than fat stores, or due to a reduction in clearance.17 
 
Cholesterol  
 Cholesterol is a fat-like substance which can be found within the body and 
consumed food.56 Cholesterol is needed to make hormones and with the aid of digestion 
of food. 56 Cholesterol travels though the bloodstream as a lipoprotein, which are lipids 
surrounded by proteins.56 There are 2 types of lipoproteins; low-density lipoprotein 
(LDL) and high-density lipoprotein (HDL). 56 High levels of LDL lead to buildup of 
cholesterol (plaque) in your arteries increasing risk of heart disease.56 High levels of HDL 
are desirable due to HDL’s ability to carry cholesterol from various parts of the body 
back to the liver.56 Having a balance of healthy levels of LDL and HDL is important for 
overall health.56 It has been hypothesized that the increased cholesterol is due to the 
mobilization of cholesterol from fat deposits at higher rates during fat mobilization.57 
Hypercholesterolemic response has been established during late phase starvation.17,57 
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Conclusion 
 As high energy exercise in the elite sport realm has been popular (e.g., soccer, 
cycling, running, etc.); non-traditional sports such as dance, horse racing, and jujitsu 
along with a new fad of sports such as Crossfit©, ultramarathons, extreme challenge 
races and triathlons has developed.  The increase participation in high-energy exercise 
has changed from purely elite sport participation to the recreational athlete.  There is 
inadequate research on the negative health outcomes and physiological effects associated 
with male athletes participating in high-energy expenditure activities with decreased 
energy needs with or without an ED/DE. Limited research has demonstrated males have 
similar mechanisms associated with the Triad; however, it is unclear the extent of these 
outcomes. Understanding the physiological demands and consequences of energy needs 
in male athletes is critical for their energy balance, injury and illness prevention, and 
counteracting long-term negative health consequences. Ultimately, insights on the near 
and long-term health outcomes for male athletes need to be provided.
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CHAPTER 5 
METHODS 
Research Design and Setting 
This study will implement a cross-sectional design within the Southeastern region 
of the United States.  Independent variables include recreational male endurance athletes 
(distance runners n=16).  Dependent variables include energy availability, energy 
expenditure, dietary intake, bone mineral density (BMD), reproductive (Testosterone (T) 
and Luteinizing hormone (LH) and metabolic (Insulin and Insulin-like growth hormone-I 
(IFG-I) Leptin, Cholesterol, and Cortisol) hormone profile.  Anthropometric 
measurements including age, height, weight, and sport participation history will be 
surveyed.    
 
Participants 
 A convenience sample of endurance trained male athletes (18-30 years) will be 
recruited from local recreational clubs and organizations (n=~16).  Participants will be 
required to be independent of any injury that would prevent them from full participation 
in a high-endurance sport (running) prior to participation in the study.  Specific inclusion 
criteria for participation includes: participant is male, within a competitive season and 
actively training and racing >10 hours/week for at least 3 months,6,17,58 has a body fat 
percentage < 12%,6,16,17,20,58 has maintained weight stability (+ 3 kg in past 6 months),18 
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and has a VO2max that is considered excellent for age specific range (18-20 years: 
Excellent 51.0-55.9; Superior >55.9 ml/kg/min, 20-29 years: Excellent 46.5-52.4; 
Superior >52.4 ml/kg/min, 30-39 years: Excellent 45.0-49.4; Superior >49.4 ml/kg/min). 
18,59 Specific exclusion criteria includes no history of smoking, past or present diagnosis 
of clinical eating disorder, infectious disease within past 4 weeks, history of 
cardiovascular disease or orthopedic impairment that interferes with moderate to vigorous 
exercise, no history of thyroid or pituitary disease, use of medication, diabetes mellitus, 
known metabolic disease, and no long term steroid use.  Internal Review Board approval 
will be obtained prior to the start of the study and all participants will sign consent forms 
prior to participation.   
 
Instrumentation 
 Basic Demographic Survey:  Basic demographic information will be collected 
including the age, education level, ethnicity, exercise background, and pertinent medical 
history questions including known metabolic diseases, history of cardiovascular, thyroid, 
or pituitary disease, and long-term steroid use.   
 Anthropometric Measurements: Multiple anthropometric measurements will be 
collected including height, weight, and body composition, which will be measured 
according to ACSM standardized procedures.26 Height will be measured with a 
Stadiomometer (Shorr Productions, Maryland) to the nearest 0.1 cm.  Weight will be 
measured wearing minimal clothes to the nearest .01 kg with a scale (Tanita, 331S, 
Tokyo, Japan). Body fat will be assessed using Tanita scale (Tanita SC-331S Body 
Composition Scale, Tanita Co., Tokyo, Japan), and Dual-Energy X-Ray Absorptiometry 
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(DXA) (GE Lunar Prodigy densitometer).  All skin folds will be measured in accordance 
with ACSM standardized procedures including the following sites; thigh, triceps, 
suprailiac, chest, supscapular, mid-axillary and abdomen.26 The Tanita scale, a 
bioelectrical impedance method (BIA), and skinfolds are reliable and valid measurements 
to obtain percent body fat.60 While DXA is the gold standard, BIA and skinfold 
measurements were found to be reliable (R=0.957-0.987) with standard errors ranging 
from 0.9-1.5% fat.60 
Dual-Energy X-Ray Absorptiometry (DXA): Will be used to measure bone 
mineral density (BMD) (g/cm2) of the lumbar spine (L1-L4) total left hip, left femoral 
neck, and total body will be measured using DXA (GE Lunar Prodigy densitometer)1,26 
DXA is considered a safe method for estimating body composition and bone mineral 
density. It is the gold standard for bone mineral density assessment.26 Radiation exposure 
is less for DXA than other x-rays.  The average skin dose is 1 to 3 mrad per DXA scan, 
which is comparable to a typical weekly exposure (3.5mrad) of environmental 
background radiation.26 Participants will undergo the DXA scan after an overnight fast 
(12 hour fast), refraining from vigorous exercise at least 15 hours prior to scan, no 
caffeine and alcohol during the preceding 24 hours, and consuming a normal evening 
meal the night before.26 Scoring of BMD will be in either “normal” or “low” categories.  
These categories will be established form the T-score and Z-score.  The T-score is 
recognized the subject’s BMD score compared to the average 30 year old adult.61  Your 
Z-score is the subject’s BMD compared to the average score of subjects consisting of the 
same age, sex, weight, and ethnic or racial background.61 Scoring for the T-score is 
considered “normal” when the scores fall between -1 and +1, and will be considered 
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“low” if scores fall below -1 and  -2.5.61  Osteoporosis is a third category established with 
a T-score below -2.5.61   
Energy Availability (EA): Defined as the amount of dietary energy remaining 
after exercise, expressed as kcal/kg lean body mass (EA = (energy intake–EE) kcal/kg 
FFM·d).1 EA will be examined using dietary intake and energy expenditure over 7-days. 
Two 7-consectutive day online food logs (FoodProdigy) will examine dietary intake and 
two 7-consectutive day exercise activity log daily examine energy availability (see Total 
Energy Expenditure below).  Dietary records will be analyzed for kilocalories, 
carbohydrate, protein, and fat composition using a dietary analysis software program 
(ESHA food processor 8.0, Salem, OR).      
Energy Balance (EB): Defined as the total energy expenditure and dietary intake 
remaining at an equal level [dietary intake (kcals/day) = Total Daily Energy Expenditure 
(TDEE, kcal/day)].  Energy balance will be examined using dietary intake and TDEE 
over two 7-consectuvie days. Negative energy balance will be defined as TDEE 
(kcals/day) > dietary intake (kcals/day).1-7,9,62 
Resting Metabolic Rate (RMR): Will be used to identify how many calories are 
necessary at rest.  It will be measured using indirect calorimetry (Microlife MedGem; 
HealtheTech, Golden, CO). The MedGem is a clinically-validated measurement device 
that assesses RMR.63 While the MedGem is not the gold standard for measuring RMR; it 
is, however, clinically a very relevant tool.63 Most accurate measurements are produced 
first thing in the morning, when the patient is rested and positioned in either a seated or 
semi-reclined position in a quiet room.63 Measurements should be implemented when the 
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patient has not eaten, exercised or drank any caffeine within the last four hours.  
Procedures for the MedGem include, placing a plastic nose clip comfortably on their 
nose, and to breathe nasally and the volume of air (inspired and expired) will be 
measured by an ultrasonic sensor.  The measurement is conducted with the patient 
holding the calorimeter resting on their chest and time for completion.63 
Total Daily Energy Expenditure (TDEE): A 7-consecutive day daily training 
(exercise) log will be used to calculate TDEE. Variables such as duration, intensity of 
activity, weight, age, and gender from the Ainsworth compendium of physical activity 
will be used.64 Exercise energy expenditure (EEE) will be calculated using SenseWear 
Armbands. SenseWear armbands contain accelerometers that continuously monitor the 
individual wearing the device for TEE and EEE. The armband has been validated 
compared to indirect caliometry, double labeled water, and VO2 max metabolic cart. 
SenseWear© Software 8.0 will be used to collect, save, and analyze data from the 
armband.63-71  
Dietary Intake: Participants will record their dietary intake for two separate 
weeks, 7-consecutive days per week.  Two 7-consecutive day food records will examine 
energy intake, macronutrient intake and energy availability.  Portion sizes will be 
explained, and take-home examples given prior to food record distribution.  Dietary 
records will be analyzed for total kilocalories and macronutrients (carbohydrates, 
proteins, and fat) consumption using a dietary analysis software program (ESHA food 
processor 8.0, Salem, OR).  Research has demonstrated that despite food intake 
restrictions, reported intake accuracy was superior using a 7-consecutive day weighted-
diet record compared to a food-frequency questionnaire.      
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A 7-consectuive day food record was chosen over a 3-day food record or a food-
frequency questionnaire.72 This study examined the validity of the 7-consecutive day 
food record and confirmed the 7-consecutive day food record has greater ability to detail 
food intake.72 The 7-consecutive day food diary includes color photographs of seventeen 
foods, presenting with three different portion sizes for each food.72 Participants can 
choose with photograph representation their individual portion size or can gauge whether 
they consumed more or less than the picture depicts.72 Participants can also describe food 
intake and portion sizes in other measurements when appropriate including weights and 
household units.72 Detailed instructions on food descriptions and quantifications are 
given prior to food record distribution and during the course of the study. 72 
Exercise Energy Expenditure (EEE): A 7-consecutive day daily training log will 
be recorded.  Exercise energy expenditure will be measured two separate ways.  The first 
measurement will be calculated using the Ainsworth equation {EEE= duration(minutes) x 
((METs X 3.5 x weight (kg))/200).64 The second form of measurement will be the 
Bodymedia SenseWear Armbands (Bodymedia Inc, Pittsburgh, PA).   
Bodymedia SenseWear Armbands: The Bodymedia SenseWear armbands 
continuously monitor total daily energy expenditure and EEE during physical activities. 
The armband is non-invasive and participants can wear it in all conditions (e.g workouts, 
activities of daily life, sleeping) except to swim and shower.63,65-71 Exercise energy 
expenditure will be examined using the data from the armbands over 14-days (two 7-
consecutive day weeks). The armband has been proven to be clinically reliable in several 
studies in providing an accurate estimate of energy expenditure when compared to 
indirect calorimetry during exercise periods.63,65-71 In a comparison of energy expenditure 
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measuring devices, the BodyMedica SenseWear Armband (SWA) , the CSA, and the 
TriTrac-R3D, the SWA estimated the best total energy expenditure at most speeds.63 
Drenowatz et al.73 assessed the validity of the SWA.  Results demonstrated a celling 
effect around ten METs causing an underestimation of energy expenditure at high 
intensities (65, 75 and 85% of VO2max).73,74 To aid in this underestimation of EEE, 
participants will wear a heart rate monitor during exercise.58,75        
Heart Rate Monitor: The participants will wear a POLAR heart rate monitor 
during exercise as a secondary measure of EEE by calculating METs during exercise, 
derived from their heart rate and the corresponding percent of VO2max.  Various brands of 
heart rate monitors, including POLOAR, were found to accurately assess heart rates 
during rest and moderate activity (r > 0.90, SEE < 5 beats/min).75 Accuracy did decrease 
at the highest speed however the HR monitor will be used as a backup to the SenseWear 
Armbands to aid in calculating exercise energy expenditure.58,75   
VO2max: A VO2max treadmill test using the Bruce Protocol76 will be administered 
as part of the inclusion criterion.    The Bruce Protocol is a submaximal exercise test used 
to estimate VO2max.76 However, procedurally, the predictive equation from ACSM 
associated with the Bruce protocol will not be used, as direct measurement using a 
Cosmed K4b2 unit will be administered to measure VO2max.  Koutlianos, Dimitros, 
Metaxas, Deligiannis, and Kouidi77 examined the indirect estimation of VO2max in 
national and international athletes by the ACSM’s equation and found the Bruce protocol 
does not accurately equate in participants 18-37 years of age.77 For this reason the 
Cosmed K4b2 unit will be used as it provides good reliability and repeatability for 
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measurements of VO2 (r2 = 0.84), and VCO2 (r2 = 0.92) when compared to the metabolic 
cart measurements.78 
 
EDI-3  
The Eating Disorder Inventory-3 (EDI-3) is a self-reported survey validated to 
identify subjects with disordered eating patterns.79 The inventory includes 91 items, 
organized into 12 primary scales, consisting of three eating-disorder specific scales and 
nine general psychological scales that are relevant but not specific to eating disorders.79 
The EDI-3 yields six composite scales, five general integrative psychological constructs 
(i.e. Ineffectiveness, Interpersonal Problems, Affective Problems, Over-control, and 
overall Psychological Maladjustment composite) and one eating disorder specific 
composite (Eating Disorders Risk Composite).79   
The EDI-3 is validated for age ranges of adolescent (13 years of age) through elderly 
(53 years of age) subjects.79 Reliability for the EDI-3 composites are high.79 Coefficient 
and median values for specific composites include; Eating disorder risk (r=.98, 
median=.95) and General Psychological Maladjustment (r=.97, median=.93).79 The EDI-
3 Symptom Checklist (EDI-3 SC) provides information regarding the frequency of eating 
disorder risk behaviors or symptoms (i.e. binge eating, self-induced vomiting, exercise 
patterns, laxative use, diet pill use, and use of diuretics).79 The EDI-3 SC is a screening 
tool designed specifically for Allied Health professionals to identify individuals at risk 
for eating disorders.79 EDI-3 Inventories (EDI-3 and EDI-3 SC) are copyright surveys 
from the Psychological Assessment Resources, Inc. and permission of use is granted with 
purchase of inventory.79  
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Hormone Measures 
All fasting blood samples will be acquired during the two separate 7-consecutive 
day data collection.  Blood samples will be centrifuged, and plasma drawn out to assess 
the following hormones: Testosterone, IGF-I, LH, Cortisol, Cholesterol, and Leptin using 
enzyme-linked immunosorbent assay (ELISA) Kits specific for each hormone. 
Establishment of cutoffs will be identified as low, within normal, or high based on 
previously established normative data specific for males (adult and age range specific) 
associated to each of the 7 hormones.  The ranges include the following for reproductive 
hormones: T=270-1070 ng/dL (average 679 ng/dL)80 and LH= 1.8-12.0 mlU/mL.80,81 
Normative ranges for the dietary hormone leptin is 1.2 -9.5 ng/ml.82  Metabolism 
hormone markers are: for a fasting insulin = < 5 ulU/mL (8-10 ulU/mL is also an 
accepted range)83 and IGF-I is age specific with ages 16-24 ranging from 182-780 ng/mL 
and ages 25-39 ranging from 114-492 ng/mL.84 Steroidal hormones have multiple 
components to them.  As we will be doing a fasting morning blood draw, cortisol specific 
to the morning includes 7-28 ug/dL, however afternoon values decrease from 2-18 
ug/dL.85  Hormonal markers for cholesterol include a total cholesterol range below 200 
mg/dL, however “high” would be above 240 mg/dL.86 Specific ranges for LDL consist of 
values below 100 mg/dL while a “high” LDL is considered above 159 mg/dL.86 Ranges 
for HDL consist of values above 60 mg/dL and “low” values are considered below 40 
mg/dL.86  
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ELISA Kits  
This study will be using enzyme-linked immunosorbent assay (ELISA) kits 
specific for each of the previous mentioned hormones.  These include the hormones 
Testosterone, Leptin, Luteinizing hormone, Insulin, IGF-I, cortisol and Cholesterol.  
Research has shown enzyme-immunoassay (EIAs), an alias for ELISA, to report specific 
and highly sensitive procedures for identify various substances.  Sensitivities of EIAs are 
high, 1-10ug/liter range with the correlation coefficient were reported between 0.95-
0.99.87     
 
Detailed Procedures 
 All participants will sign consent forms and grant permission before data 
collection.  The data collection will span across 2 separate weeks consisting of one day 
for an information and initial measurement session, and two 7-consecutive day weeks 
where one week will be during a low volume-training week (LV), and one week will be 
during a high volume-training week (HV).   
Part I Recruitment:  
Participants will be recruited from local area running clubs.  An information letter 
via email will be used to give a brief overview of the study.  All participants interested 
will be asked to fill out a short information and availability sheet, so researchers can 
individually correspond with participants and set up assigned dates and times for 
informational session and anthropometric measurements.  
 
	   	  
 
129 
Part II Data Collection: 
  Informational Session: Participants will attend an orientation session prior to the 
data collection sessions begin.  This session will consist of written and verbal overview 
of the study, participant expectation, instructions from the researchers describing various 
tools during data collection including, ESHA FoodProdigy, BodyMeida SenseWear 
Armband, and POLAR Heart Rate Monitor.  The ESHA FoodProdigy website is where 
participants will record their daily food diaries and activity record.  The BodyMedia 
SenseWear Armband wear and care instructions will be dispensed to the participants.  All 
instructions will also be sent home for participants as a reference during the data 
collection time.  Contact information of the researcher will be provided for any questions 
that may present after instructional session.     
 Prior to Data Collection:  Participants will begin by completing a series of 
surveys, a brief interview, used to follow up on medical history, physical measurements 
(height, weight, and percent body fat) and resting metabolic rate (RMR).  This process 
will take roughly sixty minutes to complete this portion of the study.  Blood Draws and 
DXA scans will be scheduled for the two separate weeks of data collection.     
 Data Collection: Participants will complete two separate 7-consecutive day weeks 
at two levels of training volume (High and Low).  All equipment, BodyMedia SenseWear 
Armband, heart rate monitor and food log entry information will be passed out and 
instructions will be emailed out.  The research and participant will discuss and plan out a 
low-volume and high-volume training week to use during data collection.  Data 
collection weeks should be a “normal” week with a minimum of 5 training days/week 
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and participants must be engaged in a completive season.  The procedures for each of the 
2 weeks will be identical; the only change will be their volume load (LV and HV).     
 Training Weeks: Participants will be instructed to not change their daily/weekly 
activities and physical activity/exercise, while recording their food and daily training for 
7-consecutive days.  They will wear the armband for 23 hours/day and wear a HR 
monitor only during exercise and record HR during training for the 7-consecutive days. 
At the end of the 7-consectuve day training week, participants will come in for a fasting 
blood draw and DXA scan.  All equipment (Armband and HR monitor) will be returned 
and the next week will be scheduled.  
 
Statistical Analysis 
SPSS statistical software (Version 23; SPSS Inc, Chicago, IL) and alpha < 0.05 
will be used for all analyses.  Based upon power analysis a priori and based upon means 
of previous literature from Koehler et. al.,18 and Loucks et. al.,25 an effect  size between 
1.0 and 3.0 would yield a sample size of 6-10 subjects.  Using the Wilcoxon signed rank 
test, 16 subjects should allow for full saturation.  A regression model will be used to 
examine predicative components for energy availability cut offs.  Basic descriptive 
statistics will be used to examine demographic information (e.g height, weight, BMI, 
TDEE, EEE, etc.).  Energy availability will be calculated using the equation {EA = (EI-
EEE)/FFM}1,3-6,9,24,25 and exercise energy expenditure will be calculated from 3 methods; 
1) BodyMedia SenseWear Armband algorithm, 2) using the recorded HR as a percentage 
of VO2max to calculate METs, and 3) as well as {EEE= duration(minutes) x ((METs X 3.5 
x weight (kg))/200).64 Risk for low energy availability (LEA) will be defined as < 20 
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kcal/kg FFM·d. Frequencies and proportions with 95% confidence intervals will be 
calculated for categorical variables along with means and standard deviations for 
continuous variables. Chi-square analyses will be used to examine the proportion of 
participants classified as “at risk” of LEA, low BMD, risk for reproductive dysfunction, 
and risk for disordered eating/eating disorders and/or pathogenic behaviors (e.g., 
restrictive eating, binge eating, purging, laxatives, diet pills or diuretics to control 
weight). 
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TABLES 
 
  
Table 4.1 Study procedures and protocol for Examination of Energy Needs and Hormone 
Levels in Endurance Trained Male Athletes  
Informational 
Session 
Data Collections Concluding Session 
Prior to study High Volume  Low Volume  High Volume  Low 
Volume  
-Explain 
procedures 
 
-Consent forms 
signed 
 
-VO2 Max test 
 
-Instructions 
for data 
collection 
session 
 
-Pass out 
equipment of 
study: 
1. Armband 
2. HR monitor 
 
-Schedule: 
1. DXA scan (1 
scan) 
2. Fasting 
Blood Draws [2 
draws; 1 (HV 
week) and 1 
(LV week)] 
* Day 1 only: 
Basic survey; 
Anthropometric 
measurements and 
RMR 
 
-Record online 7-
day food record 
 
-Recording daily 
training log 
 
-Wear HR monitor 
only during 
exercise 
 
-Wear the 
armband for 23 
hours/day 
* Day 1 only: 
Basic survey; 
Anthropometric 
measurements 
and RMR 
 
-Record online 7-
day food record 
 
-Recording daily 
training log 
 
-Wear HR 
monitor only 
during exercise 
 
-Wear the 
armband for 23 
hours/day 
-Participants 
will report for 
Scheduled: 
1.Fasting 
morning blood 
draw 
2. DXA scan* 
 
-Participants 
will return all 
equipment of the 
study: 
1. Armband 
2. HR monitor 
-Participants 
will report 
for 
Scheduled: 
1.Fasting 
morning 
blood draw 
2. DXA 
scan* 
 
-Participants 
will return 
all 
equipment 
of the study: 
1. Armband 
2. HR 
monitor 
* ‘Day One’ will occur only once for 
this study, however will depend on 
which week (High or Low volume) will 
be the first week scheduled for data 
collection for each individual 
participant. 
***Data collection weeks should be a 
“normal” week (minimum of 5 
training days/week) and participants 
must be engaged in a competitive 
season*** 
*One DXA scan will occur for 
this study over the course of the 
two separate weeks.  However, 
it can be scheduled in either the 
High or Low Volume week. 
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APPENDIX A – INFORMED CONSENT 
Title of the Study: Examination of Energy Needs and Hormone Levles in Male 
Enduranced Trained Athletes.  
 
Investigators: Erin M. Moore, MS, ATC; Toni M. Torres-McGehee, PhD, ATC; David 
F. Stodden, PhD, Justin M. Goins, PhD, ATC; Clemens Drenowatz, PhD 
 
The purpose of this study is to determine the effects of high exercise energy expenditure 
(EEE) on energy availability (EA), bone mineral density (BMD) and 7 metabolic markers 
including: Testosterone (T), Luteinizing hormone (LH), Insulin, Insulin-like Growth 
factor-I (IGF-I), Cortisol, and Cholesterol.  The study is being conducted to fulfill partial 
requirements for a Doctorate degree.  You are being invited to participate in this study 
because you are between the ages of 18 and 30yrs, endurance trained, and are in good 
general health. The study will take place at the Exercise Science Laboratories at the 
University of South Carolina’s Arnold School of Public Health. If you agree to 
participate, you will be participating with approximately 15 other people.  
 
STUDY PARTICIPATION 
After signing the informed consent form, potential participants will complete a Health 
and Injury History Questionnaire. Any potential participant with a health or safety 
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concern will be required to have his questionnaire reviewed by the physician overseeing 
this study (Dr. Murphy) to determine inclusion or exclusion into the study. 
 
Prior to acceptance into the study, participants will complete a treadmill test to measure 
VO2max and have their body fat percentage measured using 7-site skinfold and Tanitia 
scale (BIA). If you agree to participate in the study the following will occur:  
 
Part One  
You will be asked to complete a series of surveys, a brief interview (follow up on 
medical history), and physical measurements (height, weight, and body composition 
using skin fold measurements and Tanita scale) and resting metabolic rate.  It will take 
roughly 60 minutes to complete this portion of the study.  All measurements will be taken 
by one of the researchers.  You will be asked to wear shorts and a tee shirt to this 
meeting.  All measurements will be taken in private (no other participants in the room).  
Some of the questions are about health behaviors and you may be somewhat 
uncomfortable answering.  You do not have to answer any questions that you feel 
uncomfortable with.  Questions asked include:  
• Age, education, type of exercise involvement  
• Drug use (e.g., anabolic steroids, alcohol, etc.),  
• Medical history  
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Part Two 
Dual Energy X-ray Absorptiometry (DXA) Scan.  
DXA is a method used to measure bone mineral density and body composition.  The 
machine uses x-rays that yield precise, high quality images of the body.  You will meet 
with one of the research investigators to schedule one DXA scan at your convenience.  
You will be asked to wear loose, comfortable clothing, and avoid clothing with belts, 
zippers, or buttons made of metal to the appointment.  During the scan, you will be asked 
to lie still on a padded table, with an x-ray generator below the table, and the imaging 
device above your body.  The DXA machine will send a thin, invisible beam of low-dose 
x-rays with two distinct energy peaks through the body.  The exposure levels from the 
DXA X-ray unit are very low.  While the radiation used for the DXA scan has no 
observable radiological or biological effect, there is always a risk associated with 
radiation exposure, even very low exposure.  If you want more information on the 
exposure levels, please contact the lead research on this study.  This procedure will take 
about 10-20 minutes.  The DXA machine, based on the standards of the DXA 
manufacturer, will automatically generate the bone mineral density measurement.  The 
scans will not be read by a radiologist and are performed for research purposes only.  The 
investigators will not go over individual results with you.  Appointments for the scan will 
be at one of the designated venues for DXA scans.   
  
Blood Work  
As part of this study, two one-time blood draw sessions are required.  You will have 
roughly 60 ml of blood taken from you twice.  The blood will be taken from the arm.  
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The total amount of blood taken for the whole study will be about 120ml.  There are 
associated risk of bruising, tenderness, fainting, and infection associated with blood draw.  
OSHA guidelines will be followed to minimizing risk.     
 
Dietary Assessment & Exercise Assessment 
In addition, you will be asked to complete a food record and a daily training log for 2 
separate consecutive weeks.  You will be asked to record all food and drinks consumed 
every day during the14 days (2 separate- 7 consecutive days) (roughly 10-15 minutes per 
day).  In addition, you will be required to log all physical activities and exercise 
(including any races) for 14 days (2 separate-7 consecutive days) (about 5-10 minutes per 
day).  Finally, you will be asked to wear an armband throughout the entire 14 days (2 
separate-7 consecutive days).  The armband should be worn at all times, including during 
sleep, but should not be worn in the water (e.g., shower, swimming, etc.).   
 
During the course of this study, you will be asked to maintain normal levels of physical 
activity and dietary food intake. 
 
 CONDITIONS 
Training Weeks  
The research and you will examine your schedule and determine the two weeks that will 
be used for data collection.  One week will be a low training volume (LV) week and the 
second will be a high training volume week (HV).   
 
	   	  
 
145 
The aim of the study is to observe the participant during his normal training sessions.  
The aim is not to induce any type of intervention or change within their eating or training 
regimens.      
 
INSTRUMENTS AND PROTOCOLS 
Treadmill VO2max Test 
Used to measure VO2max, this treadmill test progressively increases in difficulty and 
respiratory variables are measured throughout. Participants with a VO2max between 41-
60 ml/kg/min for males will be considered endurance trained and qualify to participate in 
the study.  
 
Blood Measures 
To obtain the blood we will draw blood from a vein in your arm at the end of each data 
collection week a total of 2 times. For each blood draw, we will take 7 tubes (1.2 tsp). 
Approximately 1 blood draw will be done during one data collection session for a total of 
8.4 tbsp (1/6th of what you would donate to the American Red Cross).  
 
Heart Rate  
To ensure participants remain at safe limits during the VO2max test and to determine 
exercise energy expenditure (EEE) during training runs, the participant will be given a 
Polar Heart Rate monitor and watch to use during exercise activities.  
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Diet and Activity Logs 
You will be asked to complete an online form to track your diet and activity for 2 
separate 7-consectuive day sessions.  You will be given a login and password for your 
personal account.  
 
SECURITY OF PERSONAL INFORMATION 
Participation will be confidential. To assure your confidentiality, all information 
pertaining to this study and participation will be stored in a secure and locked cabinet. 
Additionally, a code number will be assigned to each participant at the beginning of the 
project. This number will be used on project records rather than your name, and no one 
other than the researchers will be able to link your information with your name. Data 
from all participants will be analyzed together. All blood samples will be discarded after 
analysis. All data will be stored on a secure, password protected computer and only 
researchers will have access to the data. The results of this study may be reported in 
professional journals or presented at meetings; however, you will not be identified. 
 
RISKS 
As with any exercise, there is a small risk of a cardiac event due to an undetected cardiac 
condition. Heart rate will be monitored during the VO2max test and the participant will 
be able to tract their heart rate during exercise throughout the stud. All investigators are 
American Red Cross AED, CPR Professional Rescuer and First Aid certified. 
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Other risks of this study are general risks associated with exercise, such as muscle or 
tendon strains. These risks are no different from what the participant is already doing in 
his own training sessions.   
 
Risks of drawing blood include temporary discomfort from the needle stick, bruising, 
tenderness and infection. Fainting could also occur. OSHA guidelines will be followed to 
minimizing these risks. Investigators will abide by all OSHA guidelines and will be able 
to act if there is an emergency or other medical issue during the study.  
 
PARTICIPANT SAFETY 
In the event that you experience a sudden stop in your heart, during the VO2max test, 
there is access to an Automated External Defribillator (AED), room 316 of the Public 
Health Research Center and/or inside the cardio deck of the Solomon Blatt Physical 
Education Center.  All investigators are trained to use an AED and in CPR. If you 
experience any medical issues such as a cardiac event as a participant in this study, the 
investigators will provide appropriate immediate care and you will be referred for 
additional medical treatment if necessary. However, in the event you suffer from a 
research related injury, there will be no financial compensation from the investigators or 
the University of South Carolina to assist with medical fees.   
 
The investigators will terminate your participation in the study, without your consent, if 
you suffer any symptoms or conditions that the investigators believe make it inadvisable 
for you to continue in the study. In the case of a trial being terminated due to adverse 
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symptoms an incident report will be completed and given to the physician overseeing the 
study.  In the case the participant is able to continue with the study, the participant cannot 
continue until the physician has reviewed the incident report and deems it appropriate for 
the participant to continue with the study. In the case of a more severe incident (for 
example, cardiac event) the participant will not be allowed to continue in the study. 
 
BENEFITS 
Participating in this study will increase your awareness of personal training and fueling 
behaviors. Each participant will receive a personalized fueling protocol that includes 
caloric needs during exercise. The primary investigator will also be available to discuss 
the individual reports and answer any specific questions the participant has regarding 
fluid and electrolyte needs during exercise. 
 
The information from this study will be helpful for competitive athletes as well as 
recreational athletes and athletic trainers regarding energy availability and hormonal 
responses to high-energy expenditure activities in male athletes.  
 
VOLUNTARINESS 
Participation is voluntary. You may decide not to participate at all, or to stop participating 
at any time, for any reason without negative consequences. Participants wishing to 
withdraw voluntarily from the study should notify the primary investigator (Dawn 
Emerson) by phone or email. Your participation, non-participation and/or withdrawal will 
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not affect your grades or your relationship with your professors, college(s), or the 
University of South Carolina. 
 
QUESTIONS 
If you have any questions, please feel free to ask at any time. You should contact Erin M. 
Moore at (cell) (603) 860-6916 or (email) erinmm@email.sc.edu or Dr. Toni Torress-
McGehee  (email) Torresmc@mailbox.sc.edu if you have any questions or if you believe 
that you have suffered a research related injury.  
 
If you have any questions about your rights as a research subject contact, Lisa Marie 
Johnson, IRB Manager, Office of Research Compliance, University of South Carolina, 
901 Sumter Street, Byrnes 515, Columbia, SC 29208, Phone: (803) 777-7095 or 
LisaJ@mailbox.sc.edu.  The Office of Research Compliance is an administrative office 
that supports the USC Institutional Review Board.  The Institutional Review Board (IRB) 
consists of representatives from a variety of scientific disciplines, non-scientists, and 
community members for the primary purpose of protecting the rights and welfare of 
human subjects enrolled in research studies. 
 
SIGNATURES 
I have read the contents of this Consent Form.  The purpose of this study, procedures to 
be followed, risks and benefits have been explained to me. I have been allowed to ask 
questions, and my questions have been answered to my satisfaction. I have been told 
whom to contact if I have additional questions. I agree to participate in this study, 
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knowing that I may withdraw at any time. I have been given a copy of this Consent Form 
to keep for my reference. 
 
_______________ 
Date 
 
 
 
 
______________________________ _____________________________ 
Signature of Participant    Name (Please Print)   
 
 
------------------------------------------------------------------------------------------------------------
I have explained and defined in detail the research procedure in which the participant has 
agreed to participate and have offered him a copy of this informed consent form.  
 
 
_______________ 
Date 
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______________________________ _____________________________ 
Signature of Investigator   Name (Please Print) 
 
University of South Carolina 
Athletic Training Program 
Blatt PE Center 
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APPENDIX B – MEDICAL HISTORY 
Medical History Review-Interview Questions 
Are you currently, or have you in the past year, followed a 
particular “diet”? 
YES NO 
How many meals (i.g., breakfast, lunch, dinner) do you eat each 
day? 
 
How many snacks do you have each day?  
Are there certain food groups that you refuse to eat (meat, breads, 
etc.) 
 
Do you ever limit food intake to control weight? YES NO 
   If yes, do you (circle below): 
a. Decrease the amount of food you eat during the day 
b. Skip meals 
c. Limit carbohydrates intake 
d. Limit fat intake 
e. Cut out snack items 
f. Other ______________________ 
  
Do you ever feel out of control when eating or feel that you 
cannot stop eating?  
YES NO 
Do you take vitamin supplements? 
   If yes, what type: _______________________ 
   How often (daily, a few times a week?  __________________ 
 
YES No 
Do you take nutritional supplements?  
   If yes, what type: _______________________ 
   How often (daily, a few times a week?  __________________ 
YES NO 
What do you currently weight? lbs 
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Are you happy with this weight? 
   If not, what would you like to weight?  __________lbs 
YES NO 
What was the most you’ve weighed in the past year? lbs 
What was the least you’ve weighted in the past year? lbs 
Do you gain or lose weight regularly to meet the demands of your 
performance? 
YES NO 
Has anyone recommended that you change your weight or eating 
habits? 
   If yes, specify (instructor, director, etc.): 
________________________ 
YES NO 
Has anyone ever set a target weight for you or subjected you to 
routine weigh ins?  
   If yes, specify (instructor, director, etc.): 
________________________ 
YES NO 
Have you ever had to lose weight using any of the following 
methods?  
a. Vomiting 
b. Laxatives 
c. Diuretics 
d. Diet Pills 
e. Exercise 
YES No 
Do you regularly exercise outside of your normal practice 
schedule? 
   If yes, describe your activities: 
___________________________________ 
YES NO 
Have you ever been diagnosed with an eating disorder?  YES NO 
Do you think that you might have an eating disorder? YES NO 
Have you ever been treated for a stress fracture? 
   If yes, how many have you had? _______________ 
   What body part(s) were involved? ________________ 
   When did the injury occur? _____________________ 
   How was the diagnosis made (x-ray, bone scan, MRI, CT)? 
YES NO 
